1

Mohammad Reza Zali, M.D., FACG, AGAF

Personal History

Address (Office): Research Center for Gastroenterology and Liver Diseases, 7th floor,

Taleghani Hospital, Yaman St, Evin, Tehran, Iran

Phone (Office): +98 21 2417283 Fax (Office): +98 21 2402639 Email Address: nnzali@hotmail.com

Education (Academic Preparation)

- Fellowship in Gastroenterology Tulane University, New Orleans-LA, USA,

from Jan. 1977 to Dec. 1978

- Residency in Internal Medicine Tulane University, New Orleans-LA, USA,

from Jan. 1974 to Dec. 1976

- Internship - South Chicago Community Hospital, Chicago, USA, from Jan. 1973 to

Dec. 1973

- MD, Tehran University of Medical Sciences, Iran. 1963 to 1970

Posts held

- Chief, Dep. of internal Medicine, Shaheed Beheshti University of Medical Science

- Chief, Dep. of Gastroenterology and Hepatology, Shaheed Beheshti University of

Medical Science

- Chief, Research Center for Gastroenterology and Liver Diseases, Shaheed

Beheshti University of Medical Science

- Vice-Dean, Shaheed Beheshti University of Medical Science

- Board of Trustee, Shaheed Beheshti University of Medical Science

- Director of Research, Shaheed Beheshti University of Medical Science

- Deputy of Minister, Minister of Health and Medical Education-Tehran-Iran

- Director of Research, Iranian Academy of Medical Sciences

- Chief Editor of Gastroenterology and Hepatology, From Bed to Bench

Academic Appointments:

- Iranian Academy of Medical Sciences, Permanent Member, 1993 up to present

- Shaheed Beheshti University of Medical Science, Professor, 1984 up to present

- Iranian Academy of Medical Sciences, Research Director, 1993 up to present

- Ministry of Health and Education, Research Director, 1989-1993

Hospital Appointments:

- Taleghani, Internal Medicine dept. Chief, 1980 up to present

- Taleghani, Gastroenterology dept. Chief, 1980 up to present

- Mehrad, Gastroenterology dept. Chief, 1993 up to present

Professional Society Memberships:

2

- 1978: American College of Physician (Member)

- 1986: European Society of Gastroenterology (Member)

- 1995: Iranian Gastroenterology society (Member)

- 1990: Permanent member of Iranian Academy of Medical Sciences

- 1978: American Collage of Gastroenterology (Fellow)

- 1990: American Gastroenterology Association (Member)

- 2000: European Society for the Study of Liver Disease (EASL Previous member)

-2001: Iran National Science Foundation (Committee Member)

-2007: American Association for the Study of Liver Diseases (AASLD member)

Medical Licensure:

- 1975: Louisiana state licensure

- 1974: Illinois state licensure (036-049747)

- 1972: ECFMG

- 1972: Iran Medical Licensure (10680)

- 1981: American Board of Gastroenterology

- 1978: American Board of Internal Medicine

- 1980: Iranian Board of Internal Medical

- 1980: Iranian Board of Gastroenterology

Publications

a. Books

1. Rostami-Nejad M, Zali MR. Celiac disease, 2008

2. Zali MR, Colon Cancer (for Patient Education), Tehran, 2005

3. Zali MR, GI Reflux (for Patient Education), Tehran, 2005

4. Zali MR, Research in Health and Medical Sciences. Policy, management and

planning, Iranian Academy of Medical Sciences, Tehran, 1995

5. Zali MR, Patient-Physician Relationship, Iranian Academy of Medical

Sciences, Tehran, 1997

6. Azizi F, Hatami H, Janghorbani M, Zali MR et al, Epidemiology and Current

Diseases Control in Iran, Eshtiagh, Tehran, 2000

b. Articles

International

(1) Sharifan A, Tavakoli E, Ashtari S, Zali MR. Endoscopic findings in patients with

Upper gastrointestinal bleeding referred to Taleghani hospital, Tehran, Iran. Govaresh

2017;21(4):260-265.

(2) Ashtari S, Pourhoseingholi MA, Molaei M, Zali MR. Prevalence of Helicobacter

pylori and intestinal metaplasia in consecutive gastritis patients; over the period of 7

yearsn. Govaresh 2017;21(4):230-237.

3

(3) Azimirad M, Krutova M, Nyc O, Hasani Z, Afrisham L, Alebouyeh M, et al.

Molecular typing of Clostridium difficile isolates cultured from patient stool samples

and gastroenterological medical devices in a single Iranian hospital. Anaerobe

2017;47:125-128.

(4) Razaghi M, Tajeddin E, Ganji L, Alebouyeh M, Alizadeh AHM, Sadeghi A, et al.

Colonization, resistance to bile, and virulence properties of Escherichia coli strains:

Unusual characteristics associated with biliary tract diseases. Microb Pathog

2017;111:262-268.

(5) Zamani S, Hesam Shariati S, Zali MR, Asadzadeh Aghdaei H, Sarabi Asiabar A,

Bokaie S, et al. Detection of enterotoxigenic Bacteroides fragilis in patients with

ulcerative colitis. Gut Pathogens 2017;9(1).

(6) Sadeghi A, Shalmani HM, Aghdaei HA, Ardakani MJE, Zali MR, Rad N. IgG4

associated cholangiopathy: Diagnosis, treatment, and outcome. Govaresh

2017;22(3):139-148.

(7) Mirjalali H, Abbasi MR, Naderi N, Hasani Z, Mirsamadi ES, Stensvold CR, et al.

Distribution and phylogenetic analysis of Blastocystis sp. subtypes isolated from IBD

patients and healthy individuals in Iran. Eur J Clin Microbiol Infect Dis 2017:1-8.

(8) Asiabar AS, Aghdaei HA, Sabokbar A, Zali MR, Feizabadi MM. Prevalence of

adherent-invasive Escherichia coli with fimh gene isolated from Iranian patients with

ulcerative colitis. Jundishapur J Microbiol 2017;10(7).

(9) Hasani Z, Aghdaei HA, Balaii H, Azimirad M, Mirsamadi ES, Mirjalali H, et al.

The first study on opportunistic intestinal microsporidiosis in IBD patients receiving

immunosuppressive medications in Iran. Epidemiol Infect 2017;145(10):2095-2099.

(10) Moamer S, Baghestani AR, Pourhoseingholi MA, Maboudi AAK, Shahsavari S,

Zali MR, et al. Application of the parametric regression model with the four-parameter

log-logistic distribution for determining of the effecting factors on the survival rate of

colorectal cancer patients in the presence of competing risks. Iran Red Crescent Med J

2017;19(6).

(11) Azimirad M, Dezfulian A, Alebouyeh M, Bahreiny Esfehani R, Shahrokh S, Zali

MR. Infection with enterotoxigenic Staphylococcus aureus as a concern in patients with

gastroenteritis. J Global Antimicrob Resist 2017;9:111-114.

(12) Hajizadeh N, Baghestani AR, Pourhoseingholi MA, Ashtari S, Fazeli Z, Vahedi

M, et al. Trend of hepatocellular carcinoma incidence after Bayesian correction for

misclassified data in Iranian provinces. World J Hepatol 2017;9(15):704-710.

(13) Sadeghi A, Ehsani-Ardakani M-, Jamshidfar N, Rostami-Nejad M, Zali MR.

Refractory celiac disease; diagnosis, treatment and clinical manifestations. Govaresh

2017;22(1):7-16.

(14) Pourhoseingholi MA, Ashtari S, Hajizadeh N, Zali MR. Metabolic Syndrome,

Gastric Cancer Mortality and Competing Risk Survival Analysis. EBioMedicine

2017;15:4-5.

(15) Mahmoudi T, Nobakht H, Dabiri R, Maleki I, Dehghan P, Mansour-Ghanaei F, et

al. Association between insulin receptor gene exon 17 rs1799817 variant and risk of

nonalcoholic fatty liver disease. Meta Gene 2017;11:205-208.

(16) Zamani S, Zali MR, Aghdaei HA, Sechi LA, Niegowska M, Caggiu E, et al.

Mycobacterium avium subsp. paratuberculosis and associated risk factors for

inflammatory bowel disease in Iranian patients. Gut Pathogens 2017;9(1):1-10.

4

(17) Eshghifar N, Farrokhi N, Naji T, Zali MR. Tumor suppressor genes in familial

adenomatous polyposis. Gastroenterol Hepatol Bed Bench 2017;10(1):3-13.

(18) Rezasoltani S, Asadzadeh-Aghdaei H, Nazemalhosseini-Mojarad E, Dabiri H,

Ghanbari R, Zali MR. Gut microbiota, epigenetic modification and colorectal cancer.

Iran J Microbiol 2017;9(2):55-63.

(19) Mohsenzadeh M, Sadeghi RN, Vahedi M, Kamani F, Hashemi M, Asadzadeh H, et

al. Promoter hypermethylation of RAR- β tumor suppressor gene in gastric carcinoma:

Association with histological type and clinical outcomes. Cancer Biomarkers

2017;20(1):7-15.

(20) Vejdani R, Bahari A, Zadeh AM, Azmi M, Ebrahimi-Daryani N, Hashtroudi AA,

et al. Effects of lactobacillus casei probiotic on mild to moderate ulcerative colitis: A

placebo controlled study. Indian J Med Sci 2017;69(1):24-28.

(21) Ghavami SB, Chaleshi V, Derakhshani S, Aimzadeh P, Asadzadeh-Aghdaie H,

Zali MR. Association between TNF-α rs1799964 and RAF1 rs1051208 MicroRNA

binding site SNP and gastric cancer susceptibility in an Iranian population.

Gastroenterol Hepatol Bed Bench 2017;10(3):214-219.

(22) Nikzamir M, Nejad MR, Sadeghi A, Moradi A, Mohaghegh H, Asadzadeh-

Aghdaei H, et al. The correlation between endoscopy manifestations and pathology

outcome for diagnosis of celiac disease. Intl J Celiac Dis 2017;5(3):101-103.

(23) Ganji L, Azimirad M, Farzi N, Alebouyeh M, Shirazi MH, Eshraghi SS, et al.

Comparison of the detection limits of the culture and PCR methods for the detection of

Clostridium difficile, Clostridium perfringens, Campylobacter jejuni, and Yersinia

enterocolitica in human stool. Arch Pediatr Infect Dis 2017;5(1).

(24) Shokoohizadeh L, Mobarez AM, Alebouyeh M, Zali MR, Ranjbar R. Genotyping

of clinical and environmental multidrug resistant Enterococcus faecium strains. Indian J

Pathol Microbiol 2017;60(1):74-78.

(25) Rezaei-Tavirani M, Rezaei-Tavirani M, Mansouri V, Mahdavi SM, Valizadeh R,

Rostami-Nejad M, et al. Introducing crucial protein panel of gastric adenocarcinoma

disease. Gastroenterol Hepatol Bed Bench 2017;10(1):21-28.

(26) Norouzinia M, Chaleshi V, Alizadeh AHM, Zali MR. Biomarkers in inflammatory

bowel diseases: Insight into diagnosis, prognosis and treatment. Gastroenterol Hepatol

Bed Bench 2017;10(3):155-167.

(27) Chouhdari A, Yavari P, Pourhoseingholi M-, Zali M-. Participation rate and

related factors in colonoscopy screening program in first-degree relatives of patients

affected by colorectal cancer. Internat Jour of Canc Managt 2016;9(6).

(28) Haerian MS, Haerian BS, Molanaei S, Kosari F, Sabeti S, Bidari-Zerehpoosh F, et

al. MTHFR rs1801133 polymorphism and susceptibility to colorectal cancer in Iranian

population: Evidence of a case-control study and meta-analysis. Pharmacogenomics

2016;17(17):1957-1965.

(29) Azodi MZ, Peyvandi H, Rostami-Nejad M, Safaei A, Rostami K, Vafaee R, et al.

Protein-protein interaction network of celiac disease. Gastroenterol Hepatol Bed Bench

2016;9(4):268-277.

(30) Mahmoudi T, Karimi K, Karimi N, Farahani H, Nobakht H, Dabiri R, et al.

Association of adiponectin receptor 1 gene -106 C > T variant with susceptibility to

colorectal cancer. Meta Gene 2016;9:210-214.

5

(31) Ganji L, Alebouyeh M, Shirazi MH, Eshraghi SS, Mirshafiey A, Daryani NE, et al.

Dysbiosis of fecal microbiota and high frequency of Citrobacter, Klebsiella spp., and

Actinomycetes in patients with irritable bowel syndrome and gastroenteritis.

Gastroenterol Hepatol Bed Bench 2016;9(4):325-330.

(32) Rostami-Nejad M, Hejazi SH, Bahadoran M, Pestehhian N, Pourhoseingholi MA,

Hosseini-Safa A, et al. Prevalence of toxoplasma gondii and the level of IL8 in patients

with Celiac disease. Koomesh 2016;18(1):79-85.

(33) Tajeddin E, Sherafat SJ, Majidi MR, Alebouyeh M, Alizadeh AH, Zali MR.

Association of diverse bacterial communities in human bile samples with biliary tract

disorders: a survey using culture and polymerase chain reaction-denaturing gradient gel

electrophoresis methods. Eur J Clin Microbiol Infect Dis 2016;35(8):1331-1339.

(34) Dabiri R, Mahmoudi T, Farahani H, Nobakht H, Zali MR. Alanine to serine

variant at position 986 of calcium sensing receptor and colorectal cancer risk. Internat

Jour of Canc Managt 2016;9(4).

(35) Tajbakhsh M, Avini MY, Alikhajeh J, Tajeddin E, Rahbar M, Eslami P, et al.

Emergence of blaCTX-M-15, blaTEM-169 and blaPER-1 extended-spectrum β-

lactamase genes among different Salmonella enterica serovars from human faecal

samples. Infect Dis 2016;48(7):550-556.

(36) Mahmoudi T, Farahani H, Nobakht H, Dabiri R, Zali MR. Genetic variations in

leptin and leptin receptor and susceptibility to colorectal cancer and obesity. Internat

Jour of Canc Managt 2016;9(3):1-6.

(37) Khanyaghma M, Milanizadeh S, Mostafavi PG, Mohebbi SR, Valinassab T,

Azimzadeh P, et al. Distribution of Norovirus in Fecal-Contaminated Oyster

(Saccostrea cucullata and Solen roseomaculatus) Tissues in Vitro. J Aquat Food Prod

Technol 2016;25(4):607-613.

(38) Karkhane M, Pourhoseingholi MA, Kimiia Z, Mortazavi SM, Akbariyan Torkabad

MR, Hossieni Aghdam SK, et al. Attitudes toward nosocomial infections associated

mortality at intensive care units, and evaluation of the risk factors. Arch Clin Infect Dis

2016;11(2).

(39) Shahabimehr M, Alebouyeh M, Farzi N, Mahboubi A, Taslimi R, Zali MR.

Resistance rate and minimum inhibitory concentration of metronidazole among

Helicobacter pylori strains in Tehran, Iran. Arch Clin Infect Dis 2016;11(2).

(40) Koushki K, Nejad MR, Azimzadeh P, Aghdaei HA, Hajfathali A,

Pourhosseingholi MA, et al. Correlation between JAK2V617F mutation and

inflammatory bowel disease in patients referring to Taleghani hospital, Tehran.

Koomesh 2016;17(3):603-612.

(41) Hadizadeh M, Abedi SH, Malekpour H, Radinnia E, Jabbehdari S, Padashi M, et

al. Prevalence of inflammatory bowel disease among patients with primary sclerosing

cholangitis in Iran. Arab J Gastroenterol 2016;17(1):17-19.

(42) Foster GR, Coppola C, Derbala M, Ferenci P, Orlandini A, Reddy KR, et al.

Impact of safety-related dose reductions or discontinuations on sustained virologic

response in HCV-infected patients: Results from the GUARD-C Cohort. PLoS ONE

2016;11(3).

(43) Karkhane M, Pourhosiengholi MA, Torkabad MRA, Kimiia Z, Mortazavi SM,

Aghdam SKH, et al. Annual antibiotic related economic burden of healthcare

6

associated infections; A cross-sectional population based study. Iran J Pharm Res

2016;15(2):605-610.

(44) Kashfi SMH, Behboudi Farahbakhsh F, Nazemalhosseini Mojarad E, Mashayekhi

K, Azimzadeh P, Romani S, et al. Interleukin-16 polymorphisms as new promising

biomarkers for risk of gastric cancer. Tumor Biol 2016;37(2):2119-2126.

(45) Ghalehnoei H, Ahmadzadeh A, Farzi N, Alebouyeh M, Aghdaei HA, Azimzadeh

P, et al. Relationship between ureB sequence diversity, urease activity and genotypic

variations of different Helicobacter pylori strains in patients with gastric disorders. Pol

J Microbiol 2016;65(2):153-159.

(46) Ardakani MJE, Safaei A, Oskouie AA, Haghparast H, Haghazali M, Shalmani

HM, et al. Evaluation of liver cirrhosis and hepatocellular carcinoma using Protein-

Protein Interaction Networks. Gastroenterol Hepatol Bed Bench 2016;9:S14-S22.

(47) Ghasiyari H, Nejad MR, Zali MR. Immunological mediators of breast feeding to

protect against celiac disease. Intl J Celiac Dis 2016;4(3):90-91.

(48) Bastian BL, Zali MR. Entrepreneurial motives and their antecedents of men and

women in North Africa and the Middle East. Gender Manage 2016;31(7):456-478.

(49) Salehi M, Mohebbi SR, Ravanshad M, Karkhaneh M, Azimzadeh P, Pakseresht

BK, et al. Genetic association between Interleukin-12 Receptor B1 Polymorphism

(rs3746190 A/G) and susceptibility to chronic hepatitis B virus infection. J Mazandaran

Univ Med Sci 2016;25(133):111-118.

(50) Mahmoudi T, Majidzadeh-A K, Karimi K, Farahani H, Dabiri R, Nobakht H, et al.

Gly972Arg variant of insulin receptor substrate 1 gene and colorectal cancer risk in

overweight/ obese subjects. Int J Biol Markers 2016;31(1):e68-e72.

(51) Amoli AJ, Maserat E, Safdari R, Zali MR. Electronic risk assessment system as an

appropriate tool for the prevention of cancer: A qualitative study. Asian Pac J Cancer

Preven 2016;16(18):8595-8598.

(52) Habibi M, Naderi N, Farnood A, Balaii H, Dadaei T, Almasi S, et al. Association

between two single base polymorphisms of intercellular adhesion molecule 1 gene and

inflammatory bowel disease. Gastroenterol Hepatol Bed Bench 2016;9(2):87-93.

(53) Taghipour N, Molaei M, Mosaffa N, Rostami-Nejad M, Aghdaei HA, Anissian A,

et al. An experimental model of colitis induced by dextran sulfate sodium from acute

progresses to chronicity in C57BL/6: Correlation between conditions of mice and the

environment. Gastroenterol Hepatol Bed Bench 2016;9(1):45-52.

(54) Asadzadeh-Aghdaee H, Mansouri V, Peyvandi AA, Moztarzadeh F, Okhovatian F,

Lahmi F, et al. Topological and functional analysis of nonalcoholic steatohepatitis

through protein interaction mapping. Gastroenterol Hepatol Bed Bench 2016;9:S23-

S28.

(55) Malekzadeh MM, Vahedi H, Gohari K, Mehdipour P, Sepanlou SG, Daryani NE,

et al. Emerging epidemic of inflammatory bowel disease in a middle income country: A

nation-wide study from Iran. Arch Iran Med 2016;19(1).

(56) Molaei M, Farahani RK, Maftouh M, Taleghani MY, Vahdatinia M, Khatami F, et

al. Lack of BRAFV600E mutation in stage I and II of colorectal cancer. Gastroenterol

Hepatol Bed Bench 2016;9(2):94-99.

7

(57) Zali MR, Safdari R, Maserat E, Aghdaei HA. Designing clinical and genetic

guidelines of colorectal cancer screening as an effective roadmap for risk management.

Gastroenterol Hepatol Bed Bench 2016;9:S53-S61.

(58) Mojarad EN, Kashfi SMH, Mirtalebi H, Taleghani MY, Azimzadeh P, Savabkar S,

et al. Low level of microsatellite instability correlates with poor clinical prognosis in

stage II colorectal cancer patients. J Oncol 2016;2016.

(59) Tajeddin E, Rashidan M, Razaghi M, Javadi SSS, Sherafat SJ, Alebouyeh M, et al.

The role of the intensive care unit environment and health-care workers in the

transmission of bacteria associated with hospital acquired infections. J Infect Public

Health 2016;9(1):13-23.

(60) Farrokh S, Kordnaeij A, Zali MR. Factors affecting the growth of Small and

Medium-sized Enterprises. Int J Appl Bus Econ Res 2016;14(10):6199-6216.

(61) Asadzadeh-Aghdaee H, Shahrokh S, Norouzinia M, Hosseini M, Keramatinia A,

Jamalan M, et al. Introduction of inflammatory bowel disease biomarkers panel using

protein-protein interaction (PPI) network analysis. Gastroenterol Hepatol Bed Bench

2016;9:S8-S13.

(62) Tayefinasrabadi H, Hosseini SM, Mohebbi SR, Azimzadeh P, Zali MR.

Association between rs763780 polymorphism in il-17 gene and chronic hepatitis b

infection in the patients referring to Taleghani hospital, in Tehran, Iran. Sci J Kurdistan

Univ Med Sci 2016;20(6):69-75.

(63) Doregiraee F, Alebouyeh M, Fasaei BN, Charkhkar S, Tajedin E, Zali MR.

Isolation of atypical enteropathogenic and shiga toxin encoding Escherichia coli strains

from poultry in Tehran, Iran. Gastroenterol Hepatol Bed Bench 2016;9(1):53-57.

(64) Alizadeh AHM, Shahrokh S, Hadizadeh M, Padashi M, Zali MR. Diagnostic

potency of EUS-guided fna for the evaluation of pancreatic mass lesions. Endoscopic

Ultrasound 2016;5(1):30-34.

(65) Chaleshi V, Tajali R, Savabkar S, Zali N, Mojarad EN, Haghazali M, et al. Lack of

Association between NOD2 rs3135500 and IL12B rs1368439 microRNA Binding Site

SNPs and Colorectal Cancer Susceptibility in an Iranian Population. Microrna

2016;5(2):152-156.

(66) Azimirad M, Rostami-Nejad M, Rostami K, Naji T, Zali MR. The susceptibility of

celiac disease intestinal microbiota to clostridium difficile infection. Am J

Gastroenterol 2015;110(12):1740-1741.

(67) Ahmadzadeh A, Ghalehnoei H, Farzi N, Yadegar A, Alebouyeh M, Aghdaei HA,

et al. Association of CagPAI integrity with severeness of Helicobacter pylori infection

in patients with gastritis. Pathol Biol 2015;63(6):252-257.

(68) Behelgardi A, Hosseini SM, Mohebbi SR, Azimzadeh P, Derakhshani S, Karimi

K, et al. A study on genetic association of interleukin-16 single nucleotide

polymorphism (rs1131445) with chronic hepatitis B virus infection in Iranian patients.

Jundishapur J Microbiol 2015;8(11).

(69) Jahani-Sherafat S, Razaghi M, Rosenthal VD, Tajeddin E, Seyedjavadi S,

Rashidan M, et al. Device-associated infection rates and bacterial resistance in six

academic teaching hospitals of Iran: Findings from the International Nocosomial

Infection Control Consortium (INICC). J Infect Public Health 2015;8(6):553-561.

(70) Yadegar A, Alebouyeh M, Zali MR. Analysis of the intactness of Helicobacter

pylori cag pathogenicity island in Iranian strains by a new PCR-based strategy and its

8

relationship with virulence genotypes and EPIYA motifs. Infec Genet Evol 2015;35:19-

26.

(71) Kashfi SMH, Nazemalhosseini Mojarad E, Pourhoseingholi MA, Asadzadeh

Aghdaei H, Anaraki F, Zali MR. Evaluation of the left-to-right shift of colon tumors in

Iran: Is the trend changing? J Res Med Sci 2015;20(10):978-986.

(72) Fatemi SR, Pourhoseingholi MA, Asadi F, Vahedi M, Pasha S, Alizadeh L, et al.

Recurrence and five year survival in colorectal cancer patients after surgery. Internat

Jour of Canc Managt 2015;8(4).

(73) Shayganmehr F-, Alebouyeh M, Azimirad M, Aslani MM, Zali MR. Association

of tcdA+/tcdB+ clostridium difficile genotype with emergence of multidrug-resistant

strains conferring metronidazole resistant phenotype. Iran Biomed J 2015;19(3):143-

148.

(74) Mahmoudi T, Majidzadeh-A K, Karimi K, Karimi N, Farahani H, Dabiri R, et al.

An exon variant in insulin receptor gene is associated with susceptibility to colorectal

cancer in women. Tumor Biol 2015;36(5):3709-3715.

(75) Mohammad Alizadeh AH, Donboli K, Khodakarami M, Baghbani S, Reza Zali M.

Biliary stent migration to hepatic duct–case report of a late complication. Clin Med

Insights Case Rep 2015;8:13-14.

(76) Baghestani AR, Gohari MR, Orooji A, Pourhoseingholi MA, Zali MR. Evaluation

of parametric models by the prediction error in colorectal cancer survival analysis.

Gastroenterol Hepatol Bed Bench 2015;8(3):183-187.

(77) Mirfakhar FS, Hosseini SM, Mohebbi SR, Azimzadeh P, Khanyaghma M, Zali

MR. Association between interleukin-20 gene Rs 1518108 polymorphisms of and the

risk of chronic hepatitis B. Sci J Kurdistan Univ Med Sci 2015;20(2):15-23.

(78) Hossein Kashfi SM, Golmohammadi M, Farahbakhsh FB, Nazemalhos-Seini

Mojarad E, Azimzadeh P, Norouzinia M, et al. Novel missense mutation at codon 2774

(C.8321 G>A) p.S2774n of APC gene in a denovo case of familial adenomatous

polyposis. Arch Iran Med 2015;18(7):446-449.

(79) Rassouli G, Alebouyeh M, Amini B, Rassouli A, Zali MR. Contamination status of

food handlers, utensils and foodstuffs with methicillin-resistant staphylococcus aureus

strains in a hospital kitchen. J Zanjan Univ Med Sci Health Serv 2015;23(101):24-35.

(80) Ashtari S, Pourhoseingholi MA, Sharifian A, Zali MR. Hepatocellular carcinoma

in Asia: Prevention strategy and planning. World J Hepatol 2015;7(12):1708-1717.

(81) Alizadeh AHM, Afzali ES, Behzad C, Mousavi M, Mirsattari D, Doagoo SZ, et al.

Is ESR important for predicting post-ERCP pancreatitis? Clin Med Insights:

Gastroenterol 2015;8:23-27.

(82) Ashtari S, Pourhoseingholi MA, Molaei M, Taslimi H, Zali MR. The prevalence of

Helicobacter pylori is decreasing in Iranian patients. Gastroenterol Hepatol Bed Bench

2015;8:S23-S29.

(83) Farzi N, Malekian T, Alebouyeh M, Vaziri F, Zali MR. Genotype diversity and

quasispecies development of Helicobacter pylori in a single host. Jpn J Infect Dis

2015;68(3):176-180.

(84) Farahani RK, Azimzadeh P, Rostami E, Malekpour H, Aghdae HA,

Pourhoseingholi MA, et al. Evaluation of insulin like growth facror-1 genetic

9

polymorphism with gastric cancer susceptibility and clinicopathological features. Asian

Pac J Cancer Preven 2015;16(10):4215-4218.

(85) Damavand B, Derakhshani S, Saeedi N, Mohebbi SR, Milanizadeh S, Azimzadeh

P, et al. Intronic polymorphisms of the SMAD7 gene in association with colorectal

Cancer. Asian Pac J Cancer Preven 2015;16(1):41-44.

(86) Maserat E, Farajollah SSS, Safdari R, Ghazisaeedi M, Aghdaei HA, Zali MR.

Information engineering and workflow design in a clinical decision support system for

colorectal cancer screening in Iran. Asian Pac J Cancer Preven 2015;16(15):6605-6608.

(87) Shokrzadeh L, Alebouyeh M, Mirzaei T, Farzi N, Zali MR. Prevalence of multiple

drug-resistant helicobacter pylori strains among patients with different gastric disorders

in Iran. Microb Drug Resist 2015;21(1):105-110.

(88) Vaziri F, Peerayeh SN, Alebouyeh M, Maghsoudi N, Azimzadeh P, Siadat SD, et

al. Novel effects of Helicobacter pylori CagA on key genes of gastric cancer signal

transduction: A comparative transfection study. Pathog Dis 2015;73(3).

(89) Alebouyeh M, Yadegar A, Farzi N, Miri M, Zojaji H, Gharibi S, et al. Impacts of

H. pylori mixed-infection and heteroresistance on clinical outcomes. Gastroenterol

Hepatol Bed Bench 2015;8:S1-S5.

(90) Ashtari S, Pourhoseingholi MA, Zali MR. Non-alcohol fatty liver disease in Asia:

Prevention and planning. World J Hepatol 2015;7(13):1788-1796.

(91) Balaii H, Aghdaei HA, Farnood A, Habibi M, Mafi AA, Firouzi F, et al. Time

trend analysis and demographic features of inflammatory bowel disease in Tehran.

Gastroenterol Hepatol Bed Bench 2015;8(4):253-261.

(92) Dadaei T, Safapoor MH, Aghdaei HA, Balaii H, Pourhoseingholi MA, Naderi N,

et al. Effect of vitamin D3 supplementation on TNF-α serum level and disease activity

index in Iranian IBD patients. Gastroenterol Hepatol Bed Bench 2015;8(1):49-55.

(93) Sadeghi A, Shahrokh S, Zali MR. An unusual cause of constipation in a patient

without any underlying disorders. Gastroenterol Hepatol Bed Bench 2015;8(2):167-

170.

(94) Mashayekhi K, Rostami-Nejad M, Azimzadeh P, Amani D, Kazemian S,

Derakhshani S, et al. Setup of sybr green real-time PCR method to detect the HLA-DQ

alleles in patients with celiac disease. Koomesh 2015;16(4):527-535.

(95) Savabkar S, Chaleshi V, Farahbakhsh FB, Montazer Haghighi M, Zali N,

Nazemalhosseini Mojarad E, et al. VEGF gene +936C/T polymorphism decreases the

risk of colorectal cancer. Eur J Oncol 2015;20(2):88-93.

(96) Shahrokh S, Zali MR. An unusual cause of abdominal pain. Gastroenterol Hepatol

Bed Bench 2015;8(1):77-80.

(97) Gerson CD, Gerson M-, Chang L, Corazziari ES, Dumitrascu D, Ghoshal UC, et

al. A cross-cultural investigation of attachment style, catastrophizing, negative pain

beliefs, and symptom severity in irritable bowel syndrome. Neurogastroenterol Motil

2015;27(4):490-500.

(98) Rostami-Nejad M, Ishaq S, Al Dulaimi D, Zali MR, Rostami K. The role of

infectious mediators and gut microbiome in the pathogenesis of celiac disease. Arch

Iran Med 2015;18(4):244-249.

(99) Rosenthal VD, Maki DG, Mehta Y, Leblebicioglu H, Memish ZA, Al-Mousa HH,

et al. International Nosocomial Infection Control Consortiu (INICC) report, data

11

summary of 43 countries for 2007-2012. Device-associated module. Am J Infect

Control 2014;42(9):942-956.

(100) Rostami-Nejad M, Romanos J, Rostami K, Ganji A, Ehsani-Ardakani MJ,

Bakhshipour A-, et al. Allele and haplotype frequencies for HLA-DQ in Iranian celiac

disease patients. World J Gastroenterol 2014;20(20):6302-6308.

(101) Molaei R, Reza Zali M, Hasan Mobaraki M, Yadollahi Farsi J. The impact of

entrepreneurial ideas and cognitive style on students entrepreneurial intention. J Enterpr

Emerg Econ 2014;6(2):140-162.

(102) Hosseini Razavi A, Azimzadeh P, Mohebbi SR, Hosseini SM, Romani S,

Khanyaghma M, et al. Lack of association between transforming growth factor beta 1 -

509C/T and +915G/C polymorphisms and chronic hepatitis B in Iranian patients.

Hepatitis Mon 2014;14(4).

(103) Haghighi MM, Aghagolzadeh P, Zadeh SM, Molaei M, Zali MR, Radpour R.

Telomere shortening: A biological marker of sporadic colorectal cancer with normal

expression of p53 and mismatch repair proteins. Gent Test and Mol Biomarkers

2014;18(4):236-244.

(104) Ehsani-Ardakani MJ, Fallahian M, Rostami K, Rostami-Nejad M, Lotfi S,

Mohaghegh-Shalmani H, et al. Celiac disease and dysfunctional uterine bleeding; the

efficiency of gluten free diet. Bratislava Med J 2014;115(1):19-21.

(105) Roshani M, Davoodi NA, SeyyedMajidi MR, Zojaji H, Sherafat SJ, Hashemi M,

et al. Association of Helicobacter pylori with central serous chorioretinopathy in

Iranian patients. Gastroenterol Hepatol Bed Bench 2014;7(1):63-67.

(106) Rahimi M, Tajbakhsh M, Razaghi M, Tajeddin E, Alebouyeh M, Bazl MR, et al.

Frequency of β-lactamase producing isolates of Escherichia coli and their diversity in

enzyme activities among the resistance isolates from patients with diarrhea and

nosocomial infections in Tehran, Iran. Koomesh 2014;15(2):197-205.

(107) Yadegar A, Mobarez AM, Alebouyeh M, Mirzaei T, Kwok T, Zali MR. Clinical

relevance of cagL gene and virulence genotypes with disease outcomes in a

Helicobacter pylori infected population from Iran. World J Microbiol Biotechnol

2014;30(9):2481-2490.

(108) Akbari Z, Safari-Alighiarloo N, Haghighi MM, Vahedi M, Mirtalebi H,

Azimzadeh P, et al. Lack of influence of the SMAD7 gene rs2337107 polymorphism on

risk of colorectal cancer in an Iranian population. Asian Pac J Cancer Preven

2014;15(11):4437-4441.

(109) Fathi F, Ektefa F, Sohrabzadeh K, Arefi-Oskouie A, Tafazzoli M, Rostami K, et

al. A Metabonomics Study on Celiac Disease by CART. Intl J Celiac Dis 2014;2(2):44-

46.

(110) Shahrokh S, Zali MR. An unusual cause of upper gastrointestinal bleeding.

Gastroenterol Hepatol Bed Bench 2014;7(3):183-185.

(111) Khorshidi F, Haghighi MM, Mojarad EN, Azimzadeh P, Damavand B, Vahedi

M, et al. The prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) rs5277

polymorphism does not influence risk of colorectal cancer in an Iranian population.

Asian Pac J Cancer Preven 2014;15(8):3507-3511.

(112) Mirzaei T, Alebouyeh M, Shokrzadeh L, Aghdaei HA, Farzi N, Zojaji H, et al.

Smoking, proton pump inhibitors and antibiotic administration as factors affecting

11

direct screening of Helicobacter pylori infection among patients with dyspepsia. Arch

Clin Infect Dis 2014;9(2).

(113) Kishani Farahani R, Montazer Haghighi M, Asadzadeh Aghdaei H, Keshavarzi F,

Taleghani MY, Goodarzi F, et al. Adenomatous polyposis coli gene large deletions in

Iranian patients with familial adenomatous polyposis. Indian J Cancer 2014;51(3):352-

357.

(114) Nazemalhosseini-Mojarad E, Kuppen PJK, Zali MR. Human Leukocyte antigen-

G (HLA-G) and gastrointestinal malignancy. Gastroenterol Hepatol Bed Bench

2014;7(2):79-81.

(115) Tajeddin E, Alebouyeh M, Mohammad AAH, Zali MR. Relationship between

antibiotic resistance patterns and existence of class 1, 2 and 3 integrons in bacterial

isolates from human bile samples in patients with biliary tract disorders. J Zanjan Univ

Med Sci Health Serv 2014;22(94):72-82.

(116) Mahmoudi T, Karimi K, Arkani M, Farahani H, Nobakht H, Dabiri R, et al.

Parathyroid hormone gene rs6256 and calcium sensing receptor gene rs1801725

variants are not associated with susceptibility to colorectal cancer in Iran. Asian Pac J

Cancer Preven 2014;15(15):6035-6039.

(117) Rooki H, Ghayour-Mobarhan M, Pourhosseingholi M-, Azarpazhooh M-,

Ebrahimi M, Ferns G, et al. Association of LXRα polymorphisms with obesity and

obesity-related phenotypes in an Iranian population. Ann Hum Biol 2014;41(3):214-

219.

(118) Bayat M, Schøtt T, Zali MR. Firms' collaboration networks benefitting

innovation: Embeddedness in high- and low-trust culture, Denmark and Iran. Int J

Entrepreneurship Small Bus 2014;23(1-2):168-190.

(119) Shokoohizadeh L, Mohabati Mobarez A, Zali MR, Ranjbar R, Alebouyeh M.

Frequency of vancomycin -resistant Enterococcus faecium strains isolated from urinary

tract infections (UTI) in 4 hospitals of Tehran. J Zanjan Univ Med Sci Health Serv

2014;22(91):121-130.

(120) Mahmoudi T, Karimi K, Arkani M, Farahani H, Nobakht H, Dabiri R, et al. Lack

of associations between vitamin D metabolism-related gene variants and risk of

colorectal cancer. Asian Pac J Cancer Preven 2014;15(2):957-961.

(121) Seyedjavadi SS, Alebouyeh M, Mojarad ENA, Zali MR. Frequency of class 1

integron and multidrug resistance pattern among isolates of Staphylococcus aureus

from hospitalized patients and environmental samples in an intensive care unit in

Tahran, Iran. Koomesh 2014;15(3):341-349.

(122) Mahmoudi T, Karimi K, Arkani M, Farahani H, Vahedi M, Dabiri R, et al.

Resistin -420C>G promoter variant and colorectal cancer risk. Int J Biol Markers

2014;29(3):e233-e238.

(123) Arfaee F, Jamshidi S, Azimirad M, Dabiri H, Tabrizi AS, zali MR. PCR-based

diagnosis of Helicobacter species in the gastric and oral samples of stray dogs. Comp

Clin Pathol 2014;23(1):135-139.

(124) Hadizadeh M, Padashi M, Alizadeh AHM, Zali MR. Clinical, laboratory

biomarkers and imaging findings of pancreatic adenocarcinoma in Iran. Asian Pac J

Cancer Preven 2014;15(10):4349-4352.

12

(125) Tahaei SME, Mohebbi SR, Azimzadeh P, Behelgardi A, Sanati A, Mohammadi

P, et al. Prevalence of hepatitis D virus in hepatitis B virus infected patients referred to

Taleghani hospital, Tehran, Iran. Gastroenterol Hepatol Bed Bench 2014;7(3):144-150.

(126) Rooki H, Ghayour-Mobarhan M, Zali M-. Association of LXRβ rs17373080

polymorphism with obesity and obesity-related phenotypes in an Iranian population.

Iran J Endocrinology Metab 2014;15(5):443-449.

(127) Fathi F, Majari-Kasmaee L, Mani-Varnosfaderani A, Kyani A, Rostami-Nejad M,

Sohrabzadeh K, et al. 1H NMR based metabolic profiling in Crohn's disease by random

forest methodology. Magn Reson Chem 2014;52(7):370-376.

(128) Salehi Moghadam F, Mohebbi SR, Hosseini SM, Romani S, Mirtalebi H,

Azimzadeh P, et al. Phylogenetic analysis of hepatitis C virus strains and risk factors

associated with infection and viral subtypes among Iranian patients. J Med Virol

2014;86(8):1342-1349.

(129) Yadegar A, Alebouyeh M, Lawson AJ, Mirzaei T, Mojarad EN, Zali MR.

Differentiation of non-pylori Helicobacter species based on PCR-restriction fragment

length polymorphism of the 23S rRNA gene. World J Microbiol Biotechnol

2014;30(6):1909-1917.

(130) Dabiri H, Rad MA, Tavafzadeh R, Taheri E, Safakar S, Mojarad EN, et al.

Bacteriologic study of cirrhotic patients with non-neutrocytic ascites. Gastroenterol

Hepatol Bed Bench 2014;7(4):224-229.

(131) Haerian MS, Haerian BS, Rooki H, Molanaei S, Kosari F, Obohhat M, et al.

Association of 8q24.21 rs10505477-rs6983267 haplotype and age at diagnosis of

colorectal cancer. Asian Pac J Cancer Preven 2014;15(1):369-374.

(132) Rooki H, Haerian M-, Azimzadeh P, Mirhafez R, Ebrahimi M, Ferns G, et al.

Associations between C1431T and Pro12Ala variants of PPARγ gene and their

haplotypes with susceptibility to metabolic syndrome in an Iranian population. Mol

Biol Rep 2014;41(5):3127-3133.

(133) Akbari Z, Safari-Alighiarloo N, Taleghani MY, Mirfakhar FS, Aghdaei HA,

Vahedi M, et al. Polymorphism of SMAD7 gene (rs2337104) and risk of colorectal

cancer in an Iranian population: A case-control study. Gastroenterol Hepatol Bed

Bench 2014;7(4):198-205.

(134) Naderi N, Farnood A, Dadaei T, Habibi M, Balaii H, Firouzi F, et al. Association

of tumor necrosis factor alpha gene polymor-phisms with inflammatory bowel disease

in Iran. Iran J Public Health 2014;43(5):630-636.

(135) Rooki H, Ghayour-Mobarhan M, Haerian M-, Ebrahimi M, Azimzadeh P,

Heidari-Bakavoli A, et al. Lack of association between lxrα and lxrβ gene

polymorphisms and prevalence of metabolic syndrome: A case-control study of an

iranian population. Gene 2013;532(2):288-293.

(136) Ashtari S, Vahedi M, Pourhoseingholi MA, Zali MR. Evaluated outcomes in

patients with chronic hepatitis C. Gastroenterol Hepatol Bed Bench

2013;6(SUPPL.):S58-S64.

(137) Chaleshi V, Savabkar S, Dolatmoradi H, Haghighi MM, Maryan EK, Pasha S, et

al. Different frequency of epidermal growth factor rs76189946 polymorphism genotype

in Iranian colorectal cancer patients. Gastroenterol Hepatol Bed Bench

2013;6(SUPPL.):S32-S38.

13

(138) Kashfi SMH, Golmohammadi M, Behboudi F, Nazemalhosseini-Mojarad E, Zali

MR. MUTYH the base excision repair gene family member associated with polyposis

colorectal cancer. Gastroenterol Hepatol Bed Bench 2013;6(SUPPL.):S1-S10.

(139) Sadeghi RN, Sahba N, Vahedi M, Mohebbi SR, zali MR. Association of intron

and exon polymorphisms of p53 gene in Iranian patients with gastritis. Gastroenterol

Hepatol Bed Bench 2013;6(SUPPL.):S45-S51.

(140) Rezaei-Tavirani M, Safaei A, Zali MR. The association between polymorphisms

in insulin and obesity related genes and risk of colorectal cancer. Iran J Cancer Prev

2013;6(4):179-185.

(141) Akbarzadeh Baghban A, Pourhoseingholi A, Zayeri F, Ashtari S, Zali MR. Zero

inflated statistical count models for analysing the costs imposed by GERD and

dyspepsia. Arab J Gastroenterol 2013;14(4):165-168.

(142) Rostami-Nejad M, Haldane T, Aldulaimi D, Alavian SM, Zali MR, Rostami K.

The role of celiac disease in severity of liver disorders and effect of a gluten free diet on

diseases improvement. Hepatitis Mon 2013;13(10).

(143) Zali MR, Bastian BL, Qureshi S. Promoting innovation in the MENA region: The

role of social norms and individual factors in entrepreneurial networks. Int J Bus

Globalisation 2013;11(4):413-426.

(144) Rostami Nejad M, Aldulaimi D, Ishaq S, Ehsani-Ardakani MJ, Zali MR,

Malekzadeh R, et al. Geographic trends and risk of gastrointestinal cancer among

patients with celiac disease in Europe and Asian-Pacific region. Gastroenterol Hepatol

Bed Bench 2013;6(4):170-177.

(145) Shokoohizadeh L, Mobarez AM, Zali MR, Ranjbar R, Alebouyeh M, Sakinc T, et

al. High frequency distribution of heterogeneous vancomycin resistant Enterococcous

faecium (VREfm) in Iranian hospitals. Diagn Pathol 2013;8(1).

(146) Vaziri F, Najar Peerayeh S, Alebouyeh M, Mirzaei T, Yamaoka Y, Molaei M, et

al. Diversity of Helicobacter pylori genotypes in Iranian patients with different

gastroduodenal disorders. World J Gastroenterol 2013;19(34):5685-5692.

(147) Mousavi M, Salehimarzijarani B, Dadvar Z, Jalaly NY, Valizadeh N, Sotoudeh

H, et al. Relationship between continuous use of low-dose enteric-coated aspirin and

gastrointestinal injuries in patients with gastrointestinal hemorrhage. Turk J

Gastroenterol 2013;24(2):93-98.

(148) Moghadam FS, Mohebbi SR, Hosseini SM, Damav B, Zali MR. A new subtype

of hepatitis C virus genotype 3: Analysis of available evidence. Hepatitis Mon

2013;13(8).

(149) Parhizkar B, Alebouyeh M, Dezfulian A, Rad MA, Bahreini B, Nazemalhosseini

E, et al. Coexistence of enterotoxigenic Staphylococcus aureus and cytotoxic

Clostridium difficile as predisposing factors for septic shock in patients with

inflammatory bowel disease. Prz Gastroenterol 2013;8(3):206-210.

(150) Mojarad EN, Kuppen PJK, Aghdaei HA, Zali MR. The CpG island methylator

phenotype (CIMP) in colorectal cancer. Gastroenterol Hepatol Bed Bench

2013;6(3):120-128.

(151) Chaleshi V, Haghighi MM, Javadi GR, Fatemi SR, Vahedi M, Zali MR. The

effect of 5'untranslated region polymorphism in EGF gene,rs4444903, on colorectal

cancer. Gastroenterol Hepatol Bed Bench 2013;6(3):129-135.

14

(152) Chaleshi V, Haghighi MM, Savabkar S, Zali N, Vahedi M, Khanyaghma M, et al.

Correlation between the EGF gene intronic polymorphism, rs2298979, and colorectal

cancer. Oncol Lett 2013;6(4):1079-1083.

(153) Vaziri F, Najar Peerayeh S, Alebouyeh M, Molaei M, Maghsoudi N, Zali MR.

Determination of Helicobacter Pylori CagA EPIYA types in Iranian isolates with

different gastroduodenal disorders. Infec Genet Evol 2013;17:101-105.

(154) Najjar Sadeghi R, Vahedi M, Zojaji H, Zali MR. Correlation between global

genome methylation and mutation at CpG codons of p53 gene. J Dig Dis

2013;14(6):305-310.

(155) Moghaddam MA, Nejad MR, Shalmani HM, Rostami K, Mojarad EN, Aldulaimi

D, et al. The effects of gluten-free diet on hypertransaminasemia in patients with celiac

disease. Intl J Prev Med 2013;4(6):700-704.

(156) Salehi Moghadam F, Mohebbi SR, Hosseini SM, Mirtalebi H, Romani S,

Azimzadeh P, et al. Hepatitis C virus subtype 6a infection in an Iranian patient: A case

report. Jundishapur J Microbiol 2013;6(4).

(157) Ashtari S, Vahedi M, Pourhoseingholi MA, Karkhane M, Kimiia Z,

Pourhoseingholi A, et al. Direct medical care costs associated with patients diagnosed

with chronic HCV. Hepatitis Mon 2013;13(5).

(158) Ghamar Chehreh ME, Vahedi M, Pourhoseingholi MA, Ashtari S, Khedmat H,

Amin M, et al. Estimation of diagnosis and treatment costs of non-alcoholic fatty liver

disease: A two-year observation. Hepatitis Mon 2013;13(5).

(159) Mansouri M, Mousavy SJ, Ehsaei Z, Nazarian S, Zali MR, Moazzeni SM. The

codon-optimization of cfaE gene and evaluating its high expression capacity and

conserved immunogenicity in Escherichia coli. Biologicals 2013;41(3):169-175.

(160) Fathi F, Ektefa F, Tafazzoli M, Rostami K, Nejad MR, Fathi M, et al. The

concentration of serum zinc in celiac patients compared to healthy subjects in tehran.

Gastroenterol Hepatol Bed Bench 2013;6(2):92-95.

(161) Safaei A, Sobhi S, Rezaei-Tavirani M, Zali MR. Genomic and epigenetic

instability in colorectal cancer. Iran J Cancer Prev 2013;6(SUPPL.1).

(162) Ehsani-Ardakani MJ, Nejad MR, Villanacci V, Volta U, Manenti S, Caio G, et al.

Gastrointestinal and non-gastrointestinal presentation in patients with celiac disease.

Arch Iran Med 2013;16(2):78-82.

(163) Seyedmajidi S, Mirsattari D, Zojaji H, Zanganeh E, Seyyedmajidi M, Almasi S,

et al. Penbactam for Helicobacter pylori eradication: A randomised comparison of

quadruple and triple treatment schedules in an Iranian population. Arab J Gastroenterol

2013;14(1):1-5.

(164) Khorshidi F, Mohebbi SR, Haghighi MM, Taleghani MY, Azimzadeh P,

Golmohammadi M, et al. Polymorphism -765G>C in cyclooxygenase-2 and risk of

colorectal cancer. Lab Med 2013;44(2):e14-e18.

(165) Mojarad EN, Farahani RK, Haghighi MM, Aghdaei HA, Kuppen PJK, Zali MR.

Clinical implications of BRAF mutation test in colorectal cancer. Gastroenterol Hepatol

Bed Bench 2013;6(1):6-13.

(166) Salehimarzijarani B, Jalaly NY, Dadvar Z, Hemmasi G, Ashrafi M, Zali M.

Long-term quality of life after ileal pouch anal restorative proctocolectomy for

ulcerative colitis. Indian J Gastroenterol 2013;32(1):49-53.

15

(167) Milanizadeh S, Khanyaghma M, Haghighi MM, Mohebbi S, Damavand B,

Almasi S, et al. Molecular analysis of imperative polymorphisms of MLH1 gene in

sporadic colorectal cancer. Cancer Biomarkers 2013;13(6):427-432.

(168) Goudarzi M, Goudarzi H, Alebouyeh M, Azimi Rad M, Shayegan Mehr FS, Zali

MR, et al. Antimicrobial susceptibility of clostridium difficile clinical isolates in Iran.

Iran Red Crescent Med J 2013;15(8):704-711.

(169) Azizi O, Aslani MM, Azimi Rad M, Aleboujeh M, Mousavi SF, Zali MR. The

frequency of toxigenic strains of Clostridium difficile in hospitalized patients with

diarrhea in Tehran/Iran by PCR method, 2010. J Kerman Univ Med Sci

2013;20(2):129-137.

(170) Haghighi MA, Mobarez Mohabati MA, Salmanian AH, Zali MR, Moazzeni SM,

Karkhane AA. Application of bioinformatics and genetic engineering for designing

optimized cloning and overexpression of neutrophil activating protein of Helicobacter

pylori in Escherichia coli. J Zanjan Univ Med Sci Health Serv 2013;21(85):40-54.

(171) Haghighi MM, Taleghani MY, Akbari Z, Alidadi M, Mojarad EN, Molaei M, et

al. One novel PMS2 germline mutation in a patient with hereditary non polyposis

colorectal cancer. Sci J Kurdistan Univ Med Sci 2013;18(2):18-25.

(172) Haghighi MA, Mobarez AM, Salmanian AH, Moazeni M, Zali MR, Sadeghi M,

et al. In silico experiment with an-antigen-toll like receptor-5 agonist fusion construct

for immunogenic application to Helicobacter pylori. Indian J Hum Genet

2013;19(1):43-53.

(173) Shayganmehr FS, Darbouyi M, Aslani MM, Alebouyeh M, Azimirad M, Zali

MR. Frequency of resistance to common antibiotics in Iranian clostridium difficile

clinical isolates. J Isfahan Med Sch 2013;30(217):2160-2168.

(174) Baradaran Ghavami S, Mohebbi SR, Naghoosi H, Tahaei SME, Azimzadeh P,

Damavand B, et al. Association between lymphotoxin (LT-A) gene polymorphism and

susceptibility to chronic hepatitis C infection in Iranian patients. J Kerman Univ Med

Sci 2013;20(3):252-262.

(175) Dorafshan S, Alebouyeh M, Shokrzadeh L, Mirzaei T, Mojarad EN, Behzad C, et

al. Allele-specific polymerase chain reaction for detection of main gyrA Allelic variants

in Helicobacter pylori strains. Arch Clin Infect Dis 2013;8(4).

(176) Karimi K, Mahmoudi T, Karimi N, Dolatmoradi H, Arkani M, Farahani H, et al.

Is there an association between variants in candidate insulin pathway genes IGF-I,

IGFBP-3, INSR, and IRS2 and risk of colorectal cancer in the Iranian Population?

Asian Pac J Cancer Preven 2013;14(9):5011-5016.

(177) Rooki H, Haerian M-, Azimzadeh P, Ebrahimi M, Mirhafez R, Ferns G, et al.

Distribution and genotype frequency of the C1431T and pro12ala polymorphisms of the

peroxisome proliferator activator receptor gamma gene in an Iranian population. Indian

J Hum Genet 2013;19(4):423-429.

(178) Sadeghi RN, Damavand B, Vahedi Mohsen, Mohebbi SR, Zojazi H, Molaei M, et

al. Detection of p53 common intron polymorphisms in patients with gastritis lesions

from Iran. Asian Pac J Cancer Preven 2013;14(1):91-96.

(179) Razaci Hosseini A, Hosseini SM, Azimzadeh P, Mohebbbi SR, Khanyaghma M,

Sharifian A, et al. The Assosiation of promoter polymorphism of TGF-β1 (-509C>T)

with chronic hepatitis B in Iraninan patients referred to Taleghani hospital, Tehran. J

Kerman Univ Med Sci 2013;20(3):223-231.

16

(180) Rostami-Nejad M, Villanacci V, Hogg-Kollars S, Volta U, Manenti S, Reza-Zali

M, et al. Endoscopic and histological pitfalls in the diagnosis of celiac disease: A

multicentre study assessing the current practice. Rev Esp Enferm Dig 2013;105(6):326-

333.

(181) Seyedi S, Andalib A, Rezaei A, Hosseini SM, Mohebbi SR, Zali MR, et al. The

effects of isoproterenol and propranolol on cytokine profile secretion by cultured

tumor-infiltrating lymphocytes derived from colorectal cancer patients. Cell J

2012;13(4):281-289.

(182) Fathi F, Kyani A, Nejad MR, Rezaye-Tavirani M, Naderi N, Zali MR, et al. A

metabonomics study on crohn's disease using nuclear magnetic resonance spectroscopy.

HealthMED 2012;6(11):3577-3583.

(183) Mehdivand M, Zali MR, Madhoshi M, Kordnaeij A. Intellectual capital and

nano-businesses performance: The moderating role of entrepreneurial orientation. Eur J

Econ Financ Adm Sci 2012(52):147-162.

(184) Rostami Nejad M, Taghipour N, Nochi Z, Nazemalhosseini Mojarad E, Mohebbi

SR, Fasihi Harandi M, et al. Molecular identification of animal isolates of

Echinococcus granulosus from Iran using four mitochondrial genes. J Helminthol

2012;86(4):485-492.

(185) Jahani Sherafat S, Tajeddin E, Majidi MRS, Vaziri F, Alebouyeh M, Alizadeh

AHM, et al. Lack of association between Helicobacter pylori infection and biliary tract

diseases. Pol J Microbiol 2012;61(4):319-322.

(186) Moosavi A, Haghighi A, Mojarad EN, Zayeri F, Alebouyeh M, Khazan H, et al.

Genetic variability of Blastocystis sp. Isolated from symptomatic and asymptomatic

individuals in Iran. Parasitol Res 2012;111(6):2311-2315.

(187) Yeganegi S, Zali MR, Daryani MA, Kouloubandi M. The impact of social

resources of information on opportunity recognition in food industries' SMEs. Eur J

Econ Financ Adm Sci 2012(55):49-60.

(188) Mohammad Alizadeh AH, Shams Afzali E, Sanati A, Shahnazi A, Mirsattari D,

Zali MR. Cholangiographic features in opium-addicted patients at a Tertiary Hospital in

Iran. Gastroenterol Res Pract 2012.

(189) Azimzadeh P, Romani S, Mohebbi SR, Mahmoudi T, Vahedi M, Fatemi SR, et

al. Association of polymorphisms in microRNA-binding sites and colorectal cancer in

an Iranian population. Cancer Genet 2012;205(10):501-507.

(190) Aghdaei HA, Shokrzadeh L, Alebouyeh M, Molai M, Mirzaee T, Zali MR.

Correlation between the H. pylori density and urease activity in comparison to host's

histopathological disorders. HealthMED 2012;6(7):2389-2395.

(191) Aryapour H, Mahdavi M, Mohebbi SR, Zali MR, Foroumadi A. Anti-

proliferative and apoptotic effects of the derivatives from 4- aryl-4H-chromene family

on human leukemia K562 cells. Arch Pharmacal Res 2012;35(9):1573-1582.

(192) Mohebbi SR, Rostami Nejad M, Tahaei SME, Pourhoseingholi MA, Habibi M,

Azimzadeh P, et al. Seroepidemiology of hepatitis A and E virus infections in Tehran,

Iran: A population based study. Trans R Soc Trop Med Hyg 2012;106(9):528-531.

(193) Mohammad Alizadeh AH, Afzali ES, Zafar Doagoo S, Mousavi M, Mirsattari D,

Shahnazi A, et al. Preventive role of wire-guided cannulation to reduce

hyperamylasemia and pancreatitis following endoscopic retrograde

cholangiopancreatography. Diagn Ther Endosc 2012.

17

(194) Mohammad Alizadeh AH, Afzali ES, Shahnazi A, Sanati A, Mirsattari D, Zali

MR. Utility and safety of ERCP in the elderly: A comparative study in Iran. Diagn Ther

Endosc 2012.

(195) Kordnaeij A, Danaeefard H, Zali MR, Vasheghani S. The role of organizational

culture in customer satisfaction. Eur J Econ Financ Adm Sci 2012(51):146-157.

(196) Ebrahimkhani S, Asgharian AM, Nourinaier B, Ebrahimkhani K, Vali N, Abbasi

F, et al. Association of GSTM1, GSTT1, GSTP1 and CYP2E1 single nucleotide

polymorphisms with colorectal cancer in Iran. Pathol Oncol Res 2012;18(3):651-656.

(197) Mirsattari D, Afzali ES, Zojaji H, Naderi N, Almasi S, Khalilimaryan E, et al.

New sequential versus triple treatment schedules for Helicobacter pylori eradication in

Iran. Govaresh 2012;17(2):116-121.

(198) Rezaei-Tavirani M, Fathi F, Darvizeh F, Zali MR, Nejad MR, Rostami K, et al.

Advantage of applying OSC to 1H NMR-based metabonomic data of celiac disease. Int

J Endocrinol Metab 2012;10(3):548-552.

(199) Pourhoseingholi MA, Fazeli Z, Moghimi-Dehkordi B, Vahedi M,

Pourhoseingholi A, Safaee A, et al. Increased oesophageal cancer mortality rate in Iran.

Arab J Gastroenterol 2012;13(2):82-84.

(200) Ashtari S, Vahedi M, Pourhoseingholi MA, Pourhoseingholi A, Safaee A,

Moghimi-Dehkordi B, et al. Estimation of average diagnosis and treatment costs of

hepatitis C. Gastroenterol Hepatol Bed Bench 2012;5(3):139-145.

(201) Bozorgi SM, Tahaei SME, Mohebbi SR, Sahba N, Damavand B, Romani S, et al.

Molecular prevalence of JC virus in Tehran, Iran. Gastroenterol Hepatol Bed Bench

2012;5(2):84-89.

(202) Nazemalhosseini-Mojarad E, Azimirad M, Nochi Z, Romani S, Tajbakhsh M,

Rostami-Nejad M, et al. Sequence diversity in tRNA gene locus A-L among Iranian

isolates of entamoeba dispar. Iran J Parasitol 2012;7(1):97-103.

(203) Ghobakhlou M, Mohammad Alizadeh AH, Naderi N, Haghighi S, Molaei M,

Rafiezadeh M, et al. A patient with chronic hepatitis C and a pancreatic mass in

endoscopic ultrasound. Case Rep Gastroenterol 2012;6(2):387-393.

(204) Tajbakhsh M, García Migura L, Rahbar M, Svendsen CA, Mohammadzadeh M,

Zali MR, et al. Antimicrobial-resistant Shigella infections from Iran: An overlooked

problem? J Antimicrob Chemother 2012;67(5):1128-1133.

(205) Mahmoudi T, Arkani M, Karimi K, Safaei A, Rostami F, Arbabi E, et al. The

24817 G>A (rs2238136) variant of the vitamin D receptor gene: A probable risk factor

for colorectal cancer. Mol Biol Rep 2012;39(5):5277-5282.

(206) Arvand J, Shafiabadi A, Falsafinejad MR, Zali MR. The effects of group

solution- focused therapy on depression and completion of treatment in patients with

chronic hepatitis B. HealthMED 2012;6(3):925-929.

(207) Ghobakhlou M, Fatemi SR, Dezfouli AA, Tirgary F, Zali MR. Long-term

dysphagia due to bronchogenic cyst of the esophagus. Endoscopy 2012;44(SUPPL.

2):E129-E130.

(208) Khoshbaten M, Nejad MR, Ansarin K, Fatemi R, Al Dulaimi D, Derakhshan F, et

al. The association between clinical symptoms, laboratory findings and serum

endothelin 1 concentrations, in cirrhotic patients with and without hepatopulmonary

syndrome. Gastroenterol Hepatol Bed Bench 2012;5(SUPPL. 1):S13-S19.

18

(209) Dezfulian A, Aslani MM, Oskoui M, Farrokh P, Azimirad M, Dabiri H, et al.

Identification and characterization of a high vancomycin-resistant Staphylococcus

aureus harboring VanA gene cluster isolated from diabetic foot ulcer. Iran J Basic Med

Sci 2012;15(2):803-806.

(210) pourhoseingholi A, Vahedi M, Pourhoseingholi MA, Ashtari S, Moghimi-

Dehkordi B, Safaee A, et al. Irritable bowel syndrome, gastro-oesophageal reflux

disease and dyspepsia: Overlap analysis using loglinear models. Arab J Gastroenterol

2012;13(1):20-23.

(211) Romani S, Mohebbi SR, Hosseini SM, Azimzadeh P, Vahedi M, Derakhshan F,

et al. Prevalence of Norovirus Infection in Children and Adults with Acute

Gastroenteritis, Tehran, Iran, 2008-2009. Food Environ Virol 2012;4(1):1-5.

(212) Kordnaeij A, Zali MR, Mohabatian A, Forouzandeh S. Alignment of IT strategies

with grand strategies: BSC approach. Eur J Econ Financ Adm Sci 2012(46):147-157.

(213) Safaee A, Fatemi SR, Moghimi-Dehkordi B, Ghiasi S, Zali MR. Epidemiology

and histopathological features of esophageal cancer. East Afr J Public Health

2012;9(1):7-9.

(214) Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Damavand B, Azimzadeh P,

Derakhshan F, et al. Characterization of hepatitis B virus genome variability in Iranian

patients with chronic infection, a nationwide study. J Med Virol 2012;84(3):414-423.

(215) Tajbakhsh M, Hendriksen RS, Nochi Z, Zali MR, Aarestrup FM, Garcia-Migura

L. Antimicrobial resistance in Salmonella spp. recovered from patients admitted to six

different hospitals in Tehran, Iran from 2007 to 2008. Folia Microbiol 2012;57(2):91-

97.

(216) Tahaei SME, Mohebbi SR, Zali MR. Enteric hepatitis viruses. Gastroenterol

Hepatol Bed Bench 2012;5(1):7-15.

(217) Norouzinia M, Asadzadeh H, Shalmani HM, Dulaimi DA, Zali MR. Clinical and

histological indicators of proximal and distal gastric cancer in eight provinces of Iran.

Asian Pac J Cancer Preven 2012;13(11):5677-5679.

(218) Khanizadeh S, Ravanshad M, Mohebbi SR, Naghoosi H, Tahaei MA, Nasab

SDM, et al. Polymorphisms within the promoter region of the gamma interferon (IFN-

γ) receptor1 gene are associated with the susceptibility to chronic HBV infection in an

Iranian population. Hepat Mon 2012;12(11).

(219) Karimi K, Arkani M, Safaei A, Vahedi M, Mohebi SR, Fatemi SR, et al.

Relationship between insulin receptor (INSR rs 1799817) and colorectal cancer (CRC).

J Mazandaran Univ Med Sci 2012;22(92):29-35.

(220) Fazeli Z, Pourhoseingholi MA, Vahedi M, Zali MR. Burden of hepatocellular

carcinoma in Asia. Asian Pac J Cancer Preven 2012;13(12):5955-5958.

(221) Arkani M, Karimi K, Safaei A, Vahedi M, Mohebi R, Fatemi R, et al.

Association of IGFBP3 gene (rs2854744) polymorphism and colorectal cancer. J Babol

Univ Med Sci 2012;14(3):46-51.

(222) Arkani M, Safaei A, Karimi K, Arbabi E, Rostami F, Iman M, et al. Association

of the insulin gene polymorphism and colorectal cancer. Koomesh 2012;13(2):172-176.

(223) Salehimarzijarani B, Dadvar Z, Mousavi M, Mirsattari D, Zali MR, Alizadeh

AHM. Risk factors for post-ERCP cholangitis in patients with pancreatic cancer from a

single referral center in Iran. Asian Pac J Cancer Preven 2012;13(4):1539-1541.

19

(224) Moghaddam MA, Zali MR, Andabili SHA, Derakhshan F, Miri SM, Alavian SM.

High rate of virological response to peginterferon α-2a-ribavirin among non-cirrhotic

Iranian hemophilia patients with chronic hepatitis C. Iran Red Crescent Med J

2012;14(8):2.

(225) Safaee A, Moghimi-Dehkordi B, Fatemi SR, Maserat E, Zali MR. Association of

stomach cancer risk in individuals with family history of cancer. Koomesh

2012;13(2):264-268.

(226) Mohammad-Alizadeh AH, Ghobakhlou M, Shalmani HM, Zali MR.

Cholangiocarcinoma: An-eight-year experience in a tertiary-center in Iran. Asian Pac J

Cancer Preven 2012;13(11):5381-5384.

(227) Mortazavi SH, Zali MR, Raoufi M, Nadji M, Kowsarian P, Nowroozi A. The

prevalence of human papillomavirus in cervical cancer in Iran. Asian Pac J Cancer

Preven 2012;3(1):69-72.

(228) Safaee A, Fatemi SR, Ashtari S, Vahedi M, Moghimi-Dehkordi B, Zali MR. Four

years incidence rate of colorectal cancer in iran: A survey of national cancer registry

data - implications for screening. Asian Pac J Cancer Preven 2012;13(6):2695-2698.

(229) Tahaei SME, Fatemi SR, Mohebbi SR, Mohammadi P, Nemati Malek F,

Azimzadeh P, et al. Study of anti-htlv-1 antibody frequency in gastric cancer and

colorectal cancer patients in compare to control group. J Babol Univ Med Sci

2012;14(6):91-96.

(230) Pourhoseingholi MA, Abadi A, Faghihzadeh S, Pourhoseingholi A, Vahedi M,

Moghimi-Dehkordi B, et al. Bayesian analysis of esophageal cancer mortality in the

presence of misclassification. Ital J Public Health 2011;8(4):342-347.

(231) Taghipour N, Nazemalhosseini-Mojarad E, Haghighi A, Rostami-Nejad M,

Romani S, Keshavarz A, et al. Molecular epidemiology of cryptosporidiosis in Iranian

children, Tehran, Iran. Iran J Parasitol 2011;6(4):41-45.

(232) Zali MR, Nejad MR, Al Dulaimi D, Rostami K. Nail changes: Unusual

presentation of celiac disease. Am J Gastroenterol 2011;106(12):2202-2204.

(233) Sayadi S, Darboue M, Dabiri H, Shokrzadeh L, Mirzaee T, Alebouyeh M, et al.

Study of antibiotic resistant H. pylori isolated from Iranian patients during 2009-2010.

HealthMED 2011;5(6 SUPPL. 1):1970-1976.

(234) Moghimi-Dehkordi B, Safaee A, Vahedi M, Pourhoseingholi MA,

Pourhoseingholi A, Zali MR. Population prevalence of first- and second-degree family

history of breast and ovarian cancer. East Afr J Public Health 2011;8(4):275-277.

(235) Norouzinia M, Rostami K, Amini M, Lahmi F, Roshani M, Zojaji H, et al.

Coeliac disease; prevalence and outcome in pregnancy. HealthMED 2011;5(6):1537-

1541.

(236) Taghavi A, Fazeli Z, Vahedi M, Baghestani AR, Zali MR, Pourhoseingholi MA.

Pancreatic cancer mortality and misclassification--bayesian analysis. Asian Pac J

Cancer Prev 2011;12(9):2271-2274.

(237) Azimzadeh P, Romani S, Mohebbi SR, Kazemian S, Vahedi M, Almasi S, et al.

Interleukin-16 (IL-16) gene polymorphisms in Iranian patients with colorectal cancer. J

Gastrointest Liver Dis 2011;20(4):371-376.

(238) Tahaei SME, Mohebbi SR, Azimzadeh P, Vahedi M, Almasi S, Romani S, et al.

Frequency of HIV and HCV co-infections in chronic HBV patients referred to

21

Taleghani Hospital, Tehran, Iran from 2006 to 2010. Hepatitis Mon 2011;11(12):993-

996.

(239) Alebouyeh M, Gooran OP, Azimi-Rad M, Tajbakhsh M, Tajeddin E, Jahani SS,

et al. Fatal sepsis by bacillus circulans in an immunocompromised patient. Iran J

Microbiol 2011;3(3):156-158.

(240) Biglarian A, Hajizadeh E, Kazemnejad A, Zali MR. Application of artificial

neural network in predicting the survival rate of gastric cancer patients. Iran J Public

Health 2011;40(2):80-86.

(241) Abbasinazari M, Alizadeh AHM, Moshiri K, Pourhoseingholi MA, Zali MR.

Does allopurinol prevent post endoscopic retrograde cholangio-pancreatography

pancreatitis? A randomized double blind trial. Acta Med Iran 2011;49(9):579-583.

(242) Zali N, Mohebbi SR, Esteghamat S, Chiani M, Haghighi MM, Hosseini-Asl SM-,

et al. Prevalence of ATP7B gene mutations in Iranian patients with Wilson disease.

Hepatitis Mon 2011;11(11):891-894.

(243) Romani S, Azimzadeh P, Mohebbi SR, Kazemian S, Almasi S, Naghoosi H, et al.

Investigation of transforming growth factor-β1 gene polymorphisms among Iranian

patients with chronic hepatitis C. Hepatitis Mon 2011;11(11):901-906.

(244) Nazemalhosseini-mojarad E, Azimirad M, Razaghi M, Torabi P, Moosavi A,

Alebouyeh M, et al. Frequency of Clostridium difficile among patients with

gastrointestinal complaints. Gastroenterol Hepatol Bed Bench 2011;4(4):210-213.

(245) Mahmoudi T, Karimi K, Mohebbi SR, Fatemi SR, Zali MR. Start codon FokI and

intron 8 BsmI variants in the vitamin D receptor gene and susceptibility to colorectal

cancer. Mol Biol Rep 2011;38(7):4765-4770.

(246) Frootan M, Choobtashani S, Azargashb E, Amin PM, Hamide M, Zali MR, et al.

Non-erosive reflux disease compared with erosive esophagitis with regards to acid

reflux and symptom patterns. Turk J Gastroenterol 2011;22(5):464-471.

(247) Molaei M, Yadollahzadeh M, Almasi S, Shivarani S, Fatemi S, Zali MR.

Sporadic colorectal polyps and mismatch repair proteins. Indian J Pathol Microbiol

2011;54(4):725-729.

(248) Moghimi-Dehkordi B, Vahedi M, Pourhoseingholi MA, Khoshkrood Mansoori

B, Safaee A, Habibi M, et al. Economic burden attributable to functional bowel

disorders in Iran: A cross-sectional population-based study. J Dig Dis 2011;12(5):384-

392.

(249) Sharifi Yazdi MK, Soltan-Dallal MM, Zali MR, Avadisians S, Bakhtiari R.

Incidence and antibiotic susceptibilities of Yersinia enterocolitica and other Yersinia

species recovered from meat and chicken in Tehran, Iran. Afr J Micro Res

2011;5(18):2649-2653.

(250) Mohammad Alizadeh AH, Roshani M, Lahmi F, Ahangar Davoodi N, Rostami

Nejad M, Seyyedmajidi MR, et al. Cholangiocarcinoma in magnetic resonance

cholangiopancreatography and fascioliasis in endoscopic ultrasonography. Case Rep

Gastroenterol 2011;5(3):569-577.

(251) Mohebbi SR, Sanati A, Cheraghipour K, Nejad MR, Shalmani HM, Zali MR.

Hepatitis C and hepatitis B virus infection: Epidemiology and risk factors in a large

cohort of pregnant women in Lorestan, West of Iran. Hepatitis Mon 2011;11(9):736-

739.

21

(252) Seyyedmajidi M, Falaknazi K, Mirsattari D, Zojaji H, Roshani M, Lahmi F, et al.

Correlation between creatinine clearance and Helicobacter pylori infection eradication

with sequential and triple therapeutic regimens: A randomised clinical trial. Arab J

Gastroenterol 2011;12(3):150-153.

(253) Alavian SM, Lankarani KB, Aalaei-Andabili SH, Pouryasin A, Daryani NE,

Toosi MN, et al. Treatment of chronic hepatitis C infection: Update of the

recommendations from scientific leader's meeting-28th july 2011-Tehran, IR Iran.

Hepatitis Mon 2011;11(9):703-713.

(254) Rostaminejad M, Pourhoseingholi MA, Tahaei SME, Habibi M, Azimzadeh P,

Derakhshan F, et al. Seroepidemiologic study of HAV infection in Tehran province: A

population based study. Sci J Kurdistan Univ Med Sci 2011;16(2):86-92.

(255) Safaee A, Moghimi-Dehkordi B, Fatemi SR, Maserat E, Ghafarnejad F, Zali MR.

Family history as a risk for upper gastrointestinal tract cancer: A case control study.

Iran J Cancer Prev 2011;4(3):114-119.

(256) Nejad MR, Rostami K, Zali MR. Hepatitis B vaccination reliability in celiac

disease. Hepatitis Mon 2011;11(8):597-598.

(257) Azimzadeh P, Mohebbi SR, Romani S, Kazemian S, Mirtalebi H, Vahedi M, et

al. Role of TGF-β1 codon 10 polymorphism in chronic hepatitis C patients. J Babol

Univ Med Sci 2011;13(4).

(258) Moghimi-Dehkordi B, Safaee A, Vahedi M, Pourhoseingholi MA, Habibi M,

Pourhoseingholi A, et al. Association between perceived depression, anxiety and stress

with body mass index: Results from a community-based cross-sectional survey in Iran.

Ital J Public Health 2011;8(2):128-136.

(259) Lahmi F, Roshani M, Khosravi K, Azizi M, Mohebbi SR, Zali MR. Dubin-

Johnson syndrome presenting after acute viral hepatitis. Gastroenterol Hepatol Bed

Bench 2011;4(3):164-166.

(260) Shokrzadeh L, Jafari F, Dabiri H, Baghaei K, Zojaji H, Alizadeh AH, et al.

Antibiotic susceptibility profile of Helicobacter pylori isolated from the dyspepsia

patients in Tehran, Iran. Saudi J Gastroenterol 2011;17(4):261-264.

(261) Mojarad EN, Taghipour N, Haghighi A, Keshavarz A, Nejad MR, Zali MR. DNA

fingerprinting of bovine cryptosporidium isolates in Qazvin province, Iran. Koomesh

2011;12(4).

(262) Zali MR, Alebouyeh M, Tajbakhsh M. Emergence of resistant salmonella spp.;

new challenges, new trends. Gastroenterol Hepatol Bed Bench 2011;4(3):99-101.

(263) Nazemalhosseini-Mojarad E, Haghighi A, Taghipour N, Keshavarz A, Mohebi

SR, Zali MR, et al. Subtype analysis of Cryptosporidium parvum and Cryptosporidium

hominis isolates from humans and cattle in Iran. Vet Parasitol 2011;179(1-3):250-252.

(264) Azimzadeh P, Mohebbi SR, Romani S, Naghoosi H, Vahedi M, Kazemian S, et

al. Effect of interleukin-12 p40 subunit gene 3'-untranslated region polymorphism in

chronic HCV infection. Sci J Kurdistan Univ Med Sci 2011;16(1):10-19.

(265) Hamidian M, Sanaei M, Azimi-Rad M, Tajbakhsh M, Dabiri H, Zali M-. Fla-

typing, RAPD analysis, isolation rate and antimicrobial resistance profile of

Campylobacter jejuni and Campylobacter coli of human origin collected from hospitals

in Tehran, Iran. Ann Microbiol 2011;61(2):315-321.

22

(266) Mahdavi M, Davoodi J, Zali MR, Foroumadi A. Concomitant activation of

caspase-9 and down-regulation of IAP proteins as a mechanism of apoptotic death in

HepG2, T47D and HCT-116 cells upon exposure to a derivative from 4-aryl-4H-

chromenes family. Biomed Pharmacother 2011;65(3):175-182.

(267) Sahebekhtiari N, Nochi Z, Amin Eslampour M, Dabiri H, Bolfion M,

Taherikalani M, et al. Characterization of staphylococcus aureus strains isolated from

raw milk of bovine subclinical mastitis in tehran and mashhad. Acta Microbiol

Immunol Hung 2011;58(2):113-121.

(268) Naderi N, Farnood A, Habibi M, Zojaji H, Balaii H, Firouzi F, et al. NOD2

exonic variations in Iranian Crohn's disease patients. Int J Colorectal Dis

2011;26(6):775-781.

(269) Tajbakhsh M, Nayer BN, Motavaze K, Kharaziha P, Chiani M, Zali MR, et al.

Phylogenetic relationship of Salmonella enterica strains in Tehran, Iran, using 16S

rRNA and gyrB gene sequences. J Infect Dev Ctries 2011;5(6):465-472.

(270) Moghimi-Dehkordi B, Vahedi M, Khoshkrood Mansoori B, Kasaeian A, Safaee

A, Habibi M, et al. Economic burden of gastro-oesophageal reflux disease and

dyspepsia: A community-based study. Arab J Gastroenterol 2011;12(2):86-89.

(271) Zali MR, Nejad MR, Rostami K, Alavian SM. Liver complications in celiac

disease. Hepatitis Mon 2011;11(5):333-341.

(272) Yahyazadehfar M, Zali MR, Shababi H. Determinants of investors' financial

behaviour in tehran stock exchange. Appl Econ Lett 2011;18(7):647-654.

(273) Shemirani AI, Haghighi MM, Milanizadeh S, Taleghani MY, Fatemi SR,

Damavand B, et al. The role of kras mutations and MSI status in diagnosis of colorectal

cancer. Gastroenterol Hepatol Bed Bench 2011;4(2):70-75.

(274) Shalmani HM, Soori H, Mansoori BK, Vahedi M, Moghimi-Dehkordi B,

Pourhoseingholi MA, et al. Direct and indirect medical costs of functional constipation:

A population-based study. Int J Colorectal Dis 2011;26(4):515-522.

(275) Hamidian M, Tajbakhsh M, Tohidpour A, Rahbar M, Zali MR, Walther-

Rasmussen J. Detection of novel gyrA mutations in nalidixic acid-resistant isolates of

Salmonella enterica from patients with diarrhoea. Int J Antimicrob Agents

2011;37(4):360-364.

(276) Zali MR. Facing resistance of H. pylori infection. Gastroenterol Hepatol Bed

Bench 2011;4(1):3-11.

(277) Ranjzad F, Mahban A, Irani Shemirani A, Mahmoudi T, Vahedi M, Nikzamir A,

et al. Influence of gene variants related to calcium homeostasis on biochemical

parameters of women with polycystic ovary syndrome. J Assisted Reprod Genet

2011;28(3):225-232.

(278) Nejad MR, Rostami K, Yamaoka Y, Mashayekhi R, Molaei M, Dabiri H, et al.

Clinical and histological presentation of Helicobacter pylori and gluten related

gastroenteropathy. Arch Iran Med 2011;14(2):115-119.

(279) Nejad MR, Rostami K, Cheraghipour K, Mojarad EN, Volta U, Dulaimi DA, et

al. Celiac disease increases the risk of toxoplasma gondii infection in a large cohort of

pregnant women. Am J Gastroenterol 2011;106(3):548-549.

23

(280) Pourhoseingholi MA, Faghihzadeh S, Hajizadeh E, Gatta G, Zali MR, Abadi AR.

Trend analysis of gastric cancer and colorectal cancer mortality in Iran, 1995-2003. Iran

J Cancer Prev 2011;4(1):38-43.

(281) Hamidian M, Sanaei M, Bolfion M, Dabiri H, Zali M-, Walther-Rasmussen J.

Prevalence of putative virulence markers in campylobacter jejuni and campylobacter

coli isolated from hospitalized children, raw chicken, and raw beef in Tehran, Iran. Can

J Microbiol 2011;57(2):143-148.

(282) Pourhoseingholi MA, Pourhoseingholi A, Vahedi M, Moghimi Dehkordi B,

Safaee A, Ashtari S, et al. Alternative for the Cox regression model: Using parametric

models to analyze the survival of cancer patients. Iran J Cancer Prev 2011;4(1):1-9.

(283) Nejad MR, Mahbobipour H, Fazeli Z, Mashayekhi R, Mirsattari D, Mojarad EN,

et al. Celiac disease in dyspeptic patients. Koomesh 2011;12(2):209-214.

(284) Kordnaeij A, Zali MR, Shoraka S, Abdi R. Recognizing entrepreneurial

opportunities in passenger services (case study: RAJA Passenger Trains Company). Eur

J Sci Res 2011;50(3):317-326.

(285) Safaee A, Moghimi-Dehkordi B, Fatemi SR, Pourhoseingholi MA, Vahedi M,

Pourhoseingholi A, et al. Frequency of colorectal cancer in healthy individual's

relatives: A cross-sectional population-based study. Koomesh 2011;12(2):129-133.

(286) Shemirani AI, Haghighi MM, Zadeh SM, Fatemi SR, Taleghani MY, Zali N, et

al. Simplified MSI marker panel for diagnosis of colorectal cancer. Asian Pac J Cancer

Preven 2011;12(8):2101-2104.

(287) Haghazali M, Molaei M, Mashayekhi R, Zojaji H, Pourhoseingholi MA,

Shooshtarizadeh T, et al. Proinflammatory cytokines and thrombomodulin in patients

with peptic ulcer disease and gastric cancer, infected with Helicobacter pylori. Indian J

Pathol Microbiol 2011;54(1):103-106.

(288) Azary SY, Kalbasi H, Setayesh A, Mousavi M, Hashemi A, Khodadoostan M, et

al. Predictive value and main determinants of abnormal features of intraoperative

cholangiography during cholecystectomy. Hepatobiliary Pancreatic Dis Int

2011;10(3):308-312.

(289) Akhoond MR, Kazemnejad A, Hajizadeh E, Motlagh AG, Zali MR. Comparison

of influential factors affecting survival of patients with colon and rectum cancer using

competing risks model. Koomesh 2011;12(2):119-128.

(290) Safaee A, Moghimi-Dehkordi B, Fatemi SR, Maserat E, Zali MR. Family history

of cancer and risk of gastric cancer in Iran. Asian Pac J Cancer Preven

2011;12(11):3117-3120.

(291) Tahaei SME, Mohebbi SR, Fatemi SR, Mohammadi P, Malek FN, Azimzadeh P,

et al. Low frequency of human t-cell lymphotropic virus 1 antibodies in iranian gastric

cancer patients in comparison to controls. Asian Pac J Cancer Preven 2011;12(9):2447-

2450.

(292) Fazeli Z, Pourhoseingholi MA, Pourhoseingholi A, Vahedi M, Zali MR.

Mortality of oral cavity cancer in iran. Asian Pac J Cancer Preven 2011;12(10):2763-

2766.

(293) Pourhoseingholi MA, Pourhoseingholi A, Vahedi M, Ashtari S, Safaee A,

Moghimi-Dehkordi B, et al. Decreased trend of pancreatic cancer mortality in Iran.

Asian Pac J Cancer Preven 2011;12(1):153-155.

24

(294) Molaei M, Minakari M, Pejhan S, Mashayekhi R, Modaress Fatthi AR, Zali MR.

Intestinal leishmaniasis in acquired immunodeficiency syndrome. Iran Red Crescent

Med J 2011;13(5).

(295) Moghimi-Dehkordi B, Safaee A, Vahedi M, Pourhoseingholi MA,

Pourhoseingholi A, Habibi M, et al. Familial prevalence of cancer in Iran: A general

population estimate. Asian Pac J Cancer Preven 2011;12(1):289-295.

(296) Alizadeh MAH, Mousavi M, Salehi B, Molaei M, Khodadoostan M, Afzali ES, et

al. Biliary brush cytology in the assessment of biliary strictures at a tertiary center in

iran. Asian Pac J Cancer Preven 2011;12(10):2793-2796.

(297) Maserat E, Rahimi MM, Maserat E, Zali MR. Standard pediatric oncology data

and information technology: Necessities for cancer care management. Asian Pac J

Cancer Preven 2011;12(1):323-325.

(298) Mirsattari D, Zojaji H, Mahboubi H, Molaei M, Derakhshan F, Zali M.

Quadruple versus common triple-treatment regimens for Helicobacter pylori

eradication in the Iranian population: A randomised study. Arab J Gastroenterol

2010;11(4):187-191.

(299) Nazari MA, Malayeri SH, Pourhoseingholi MA, Mohebi SR, Zali MR.

Evaluation of zinc plasma level in Iranian cirrhotic patients due to hepatitis B and

hepatitis C. Hepatitis Mon 2010;10(1):62-64.

(300) Solhpour A, Safaee A, Pourhoseingholi MA, Moghimi-Dehkordi B, Habibi M,

Qafarnejad F, et al. Relationship between uninvestigated dyspepsia and body mass

index: a population-based study. East Afr J Public Health 2010;7(4):318-322.

(301) Safaee A, Moghimi Dehkordi B, Fatemi SR, Zali MR. Epidemiological

differences between colon cancer and rectum cancer. Iran J Cancer Prev 2010;3(4):185-

192.

(302) Sadeghi RN, Azimzadeh P, Vahedi M, Mirsattari D, Molaei M, Mohebbi SR, et

al. Profile and frequency of p53 Gene alterations in gastritis lesions from Iran.

Digestion 2010;83(1-2):65-75.

(303) Rostami-Nejad M, Rostami K, Sanaei M, Mohebbi SR, Al-Dulaimi D,

Nazemalhosseini-Mojarad E, et al. Rotavirus and coeliac autoimmunity among adults

with nonspecific gastrointestinal symptoms. Saudi Med J 2010;31(8):891-894.

(304) Molaei M, Mansoori BK, Mashayekhi R, Vahedi M, Pourhoseingholi MA,

Fatemi SR, et al. Mucins in neoplastic spectrum of colorectal polyps: Can they provide

predictions? BMC Cancer 2010;10.

(305) Haghighi MM, Taleghani MY, Mohebbi SR, Vahedi M, Fatemi SR, Zali N, et al.

Impact of EXO1 polymorphism in susceptibility to colorectal cancer. Gent Test and

Mol Biomarkers 2010;14(5):649-652.

(306) Sima H, Hekmatdoost A, Ghaziani T, Alavian SM, Mashayekh A, Zali M. The

prevalence of celiac autoantibodies in hepatitis patients. Iran J Allergy Asthma

Immunol 2010;9(3):157-162.

(307) Dezfulian A, Salehian MT, Amini V, Dabiri H, Azimirad M, Aslani MM, et al.

Catalase-negative Staphylococcus aureus isolated from a diabetic foot ulcer. Iran J

Microbiol 2010;2(3).

25

(308) Kermani NA, Jafari F, Mojarad HN, Hoseinkhan N, Zali MR. Prevalence and

associated factors of persistent diarrhoea in Iranian children admitted to a paediatric

hospital. East Mediterr Health J 2010;16(8):831-836.

(309) Alizadeh AHM, Afzali ES, Mousavi M, Moaddab Y, Zali MR. Endoscopic

retrograde cholangiopancreatography outcome from a single referral center in Iran.

Hepatobiliary Pancreatic Dis Int 2010;9(4):428-432.

(310) Mahmoudi T, Mohebbi SR, Pourhoseingholi MA, Fatemi SR, Zali MR. Vitamin

D receptor gene ApaI polymorphism is associated with susceptibility to colorectal

cancer. Dig Dis Sci 2010;55(7):2008-2013.

(311) Sorouri M, Pourhoseingholi MA, Vahedi M, Safaee A, Moghimi-Dehkordi B,

Pourhoseingholi A, et al. Functional bowel disorders in Iranian population using Rome

III criteria. Saudi J Gastroenterol 2010;16(3):154-160.

(312) Dabiri H, Bolfion M, Mirsalehian A, Rezadehbashi M, Jafari F, Shokrzadeh L, et

al. Analysis of Helicobacter pylori genotypes in Afghani and Iranian isolates. Pol J

Microbiol 2010;59(1):61-66.

(313) Khodadoostan M, Fatemi R, Maserat E, Hooshang A, Alizade M, Molaie M, et

al. Clinical and pathological characteristics of colorectal polyps in Iranian population.

East Afr J Public Health 2010;7(2):157-159.

(314) Pourhoseingholi A, Pourhoseingholi MA, Rostami-Nejad M, Rostami K,

Mirsatari D, Zojaji H, et al. Implementation of statistical analysis in the clinical

research of coeliac disease: use of probit and logit analysis. East Afr J Public Health

2010;7(2):168-170.

(315) Safaee A, Moghimi-Dehkordi B, Pourhoseingholi MA, Habibi M, Qafarnejad F,

Pourhoseingholi A, et al. Heartburn and related factors in general population in Tehran,

capital of Iran. East Afr J Public Health 2010;7(2):196-198.

(316) Moghimi Dehkordi B, Safaee A, Pourhoseingholi MA, Vahedi M, Habibi M,

Pourhoseingholi A, et al. Prevalence of positive family history of colorectal cancer in

the Iranian general population. Iran J Cancer Prev 2010;3(1):28-31.

(317) Mojarad EN, Nochi Z, Sahebekhtiari N, Nejad MR, Dabiri H, Zali MR, et al.

Discrimination of Entamoeba moshkovskii in patients with gastrointestinal disorders by

single-round PCR. Jpn J Infect Dis 2010;63(2):136-138.

(318) Pourhoseingholi A, Safaee A, Pourhoseingholi MA, Moghimi-Dehkordi B,

Habibi M, Vahedi M, et al. Prevalence and demographic risk factors of gastrointestinal

symptoms in Tehran province. Ital J Public Health 2010;7(1):42-46.

(319) Dallal MMS, Doyle MP, Rezadehbashi M, Dabiri H, Sanaei M, Modarresi S, et

al. Prevalence and antimicrobial resistance profiles of Salmonella serotypes,

Campylobacter and Yersinia spp. isolated from retail chicken and beef, Tehran, Iran.

Food Control 2010;21(4):388-392.

(320) Haghighi MM, Mohebbi SR, Pour Hoseingholi MA, Taleghani MY, Fatemi SR,

Zali MR. Association of allele 61888G>T Polymorphism VDR gene and colorectal

cancer. J Babol Univ Med Sci 2010;12(1):51-58.

(321) Rostami Nejad M, Nazemalhosseini Mojarad E, Dabiri H, Nochi Z,

Pourhoseingholi MA, Sahebekhtiari N, et al. A case-control study of Blastocystis

hominis among Iranian population. East Afr J Public Health 2010;7(1):101-104.

26

(322) Foroutan M, Norouzi A, Molaei M, Mirbagheri SA, Irvani S, Sadeghi A, et al.

Eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease.

Dig Dis Sci 2010;55(1):28-31.

(323) Safaee A, Moghimi-Dehkordi B, Pourhoseingholi MA, Vahedi M, Maserat E,

Ghiasi S, et al. Risk of colorectal cancer in relatives: A case control study. Indian J

Cancer 2010;47(1):27-30.

(324) Fatemi SR, Shivarani S, Malek FN, Vahedi M, Maserat E, Iranpour Y, et al.

Colonoscopy screening results in at risk Iranian population. Asian Pac J Cancer Preven

2010;11(6):1801-1804.

(325) Hodadoostan MK, Fatemi R, Maserat E, Alizade AHM, Molaie M, Mashaiekhy

R, et al. Clinical & pathology characteristics of colorectal polyps in iranian population.

Asian Pac J Cancer Preven 2010;11(2):557-560.

(326) Moghimi-Dehkordi B, Safaee A, Fatemi R, Ghiasi S, Zali MR. Impact of age on

prognosis in Iranian patients with gastric carcinoma: Review of 742 cases. Asian Pac J

Cancer Preven 2010;11(2):335-338.

(327) Shokrzadeh L, Baghaei K, Yamaoka Y, Dabiri H, Jafari F, Sahebekhtiari N, et al.

Analysis of 3′-end variable region of the cagA gene in Helicobacter pylori isolated from

Iranian population. J Gastroenterol Hepatol 2010;25(1):172-177.

(328) Fatemi SR, Malek FN, Shivarani S, Vahedi M, Almasi S, Maserat E, et al.

Prevalence of colorectal cancer in relatives of Iranian patients diagnosed with colorectal

cancer. Asian Pac J Cancer Preven 2010;11(1):91-93.

(329) Safaee A, Moghimi-Dehkordi B, Fatemi SR, Ghiasi S, Nemati-Malek F, Zali

MR. Characteristics of colorectal mucinous adenocarcinoma in Iran. Asian Pac J

Cancer Preven 2010;11(5):1373-1375.

(330) Molaei M, Foroughi F, Mashayekhi R, Haghazali M, Zojaji H, Jafari F, et al.

CagA status and VacA subtypes of Helicobacter pylori in relation to histopathologic

findings in Iranian population. Indian J Pathol Microbiol 2010;53(1):24-27.

(331) Pourhoseingholi MA, Fazeli Z, Zali MR, Alavian SM. Burden of hepatocellular

carcinoma in Iran; Bayesian projection and trend analysis. Asian Pac J Cancer Preven

2010;11(4):859-862.

(332) Haghighi MM, Javadi GR, Parivar K, Milanizadeh S, Zali N, Fatemi SR, et al.

Frequent MSI mononucleotide markers for diagnosis of hereditary nonpolyposis

colorectal cancer. Asian Pac J Cancer Preven 2010;11(4):1033-1035.

(333) Molaei M, Mansoori BK, Ghiasi S, Khatami F, Attarian H, Zali M. Colorectal

cancer in Iran: Immunohistochemical profiles of four mismatch repair proteins. Int J

Colorectal Dis 2010;25(1):63-69.

(334) Pourhoseingholi MA, Kaboli SA, Pourhoseingholi A, Moghimi-Dehkordi B,

Safaee A, Mansoori BK, et al. Obesity and functional constipation; a community-based

study in Iran. J Gastrointest Liver Dis 2009;18(2):151-155.

(335) Hamidian M, Tajbakhsh M, Walther-Rasmussen J, Zali M-. Emergence of

extended-spectrum β-lactamases in clinical isolates of Salmonella enterica in Tehran,

Iran. Jpn J Infect Dis 2009;62(5):368-371.

(336) Safaee A, Moghimi-Dehkordi B, Fatemi SR, Ghiasi S, Zali MR. Pathology and

prognosis of colorectal cancer. Iran J Cancer Prev 2009;2(3):137-141.

27

(337) Talaie R, Forootan M, Donboli K, Dadashzadeh N, Sadeghi A, Poorsaadat S, et

al. 24-Hour ambulatory pH-metry in patients with refractory heartburn: A prospective

study. J Gastrointest Liver Dis 2009;18(1):11-15.

(338) Nejad MR, Rostami K, Pourhoseingholi MA, Mojarad EN, Habibi M, Dabiri H,

et al. Atypical presentation is dominant and typical for coeliac disease. J Gastrointest

Liver Dis 2009;18(3):285-291.

(339) Haghighi MM, Radpour R, Mahmoudi T, Mohebbi SR, Vahedi M, Zali MR.

Association between MTHFR polymorphism (C677T) with nonfamilial colorectal

cancer. Oncol Res 2009;18(2-3):57-63.

(340) Khoshkrood-Mansoori B, Pourhoseingholi MA, Safaee A, Moghimi-Dehkordi B,

Sedigh-Tonekaboni B, Pourhoseingholi A, et al. Irritable bowel syndrome: A

population based study. J Gastrointest Liver Dis 2009;18(4):413-418.

(341) Sadeghi RN, Zojaji H, Mohebbi SR, Chiani M, Mirsattari D, Pourhoseingholi

MA, et al. Global genome methylation status in gastritis lesion in comparison with

normal adjacent tissue and its relationship with clinicopathologic findings. Yakhteh

2009;10(4):272-279.

(342) Rostami-Nejad M, Villanacci V, Mashayakhi R, Molaei M, Bassotti G, Zojaji H,

et al. Celiac disease and Hp infection association in Iran. Rev Esp Enferm Dig

2009;101(12):850-854.

(343) Safaee A, Fatemi R, Pourhoseingholi MA, Moghimi Dehkordi B, Vahedi M,

Pourhoseingholi A, et al. Positive association between diabetes mellitus and risk of

colorectal cancer. Iran J Cancer Prev 2009;2(4):189-193.

(344) Pourhoseingholi MA, Nejad MR, Rostami K, Pourhoseingholi A, Zali MR.

Underweight in adult celiac patients in the community; is screening program necessary

in low weight individuals? J Gastrointest Liver Dis 2009;18(4):516-517.

(345) Sadeghi RN, Zojaji H, Mohebbi SR, Chiani M, Vahedi M, Mirsattari D, et al.

Evaluation of global genome methylation in gastritis lesion and its correlation with

clinicopatological findings. Oncol Res 2009;17(11-12):549-558.

(346) Sendi H, Mehrab-Mohseni M, Shahraz S, Norder H, Alavian S-, Noorinayer B, et

al. CTL escape mutations of core protein are more frequent in strains of HBeAg

negative patients with low levels of HBV DNA. J Clin Virol 2009;46(3):259-264.

(347) Eesteghamati A, Gouya M, Keshtkar A, Najafi L, Zali MR, Sanaei M, et al.

Sentinel hospital-based surveillance of Rotavirus diarrhea in Iran. J Infect Dis

2009;200(SUPPL. 1):S244-S247.

(348) Amini-Bavil-Olyaee S, Herbers U, Mohebbi SR, Sabahi F, Zali MR, Luedde T, et

al. Prevalence, viral replication efficiency and antiviral drug susceptibility of rtQ215

polymerase mutations within the hepatitis B virus genome. J Hepatol 2009;51(4):647-

654.

(349) Sugimoto M, Zali MR, Yamaoka Y. The association of vacA genotypes and

Helicobacter pylori-related gastroduodenal diseases in the Middle East. Eur J Clin

Microbiol Infect Dis 2009;28(10):1227-1236.

(350) Dabiri H, Rezadehbashi M, Badami N, Aghanouri R, Ahmadi H, Khoramizadeh

MR, et al. Detection of Chlamydia pneumoniae in atherosclerotic plaques of patients in

Tehran, Iran. Jpn J Infect Dis 2009;62(3):195-197.

28

(351) Luciani S, Vardy L, Paci E, Adewole I, Sasco A, Calvacante T, et al. Cancer

prevention and population-based screening. Tumori 2009;95(5):597-609.

(352) Baghaei K, Shokrzadeh L, Jafari F, Dabiri H, Yamaoka Y, Bolfion M, et al.

Determination of Helicobacter pylori virulence by analysis of the cag pathogenicity

island isolated from Iranian patients. Dig Liver Dis 2009;41(9):634-638.

(353) Nochi Z, Sahebekhtiari N, Kharaziha P, Chiani M, Motavaze K, Dabiri H, et al.

Comparison of 16S rRNA, 23S rRNA and gyrB genes sequences in phylogenetic

relationships of Shigella isolates from Iran. Ann Microbiol 2009;59(3):615-622.

(354) Zojaji H, Talaie R, Mirsattari D, Haghazali M, Molaei M, Mohsenian N, et al.

The efficacy of Helicobacter pylori eradication regimen with and without vitamin C

supplementation. Dig Liver Dis 2009;41(9):644-647.

(355) Mojarad EN, Haghighi A, Kazemi B, Nejad MR, Abadi A, Zali MR. High

genetic diversity among Iranian Entamoeba dispar isolates based on the noncoding

short tandem repeat locus D-A. Acta Trop 2009;111(2):133-136.

(356) Biglarian A, Hajizadeh E, Kazemnejad A, Zali M. Survival analysis of gastric

cancer patients using Cox model: A five year study. Tehran Uni Med J 2009;67(5):317-

325.

(357) Ardakani MJE, Rajaei A, Shalmani HM, Shahid N, Emam MM,

Mohammadzadeh N, et al. Frequency of hepatitis C in patients with rheumatoid

arthritis. Iran J Clin Infect Dis 2009;4(1):39-43.

(358) Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Derakhshan F, Sabahi F, Zali MR.

An extremely aberrant subtype of hepatitis B virus genotype D in Iran. Hepatitis Mon

2009;9(1):73-75.

(359) Zali MR, Moaven O, Aghdaee HA, Ghafarzadegan K, Ahmadi KJ, Farzadnia M,

et al. Clinicopathological significance of E-cadherin, β-catenin and p53 expression in

gastric adenocarinoma. J Res Med Sci 2009;14(4):239-247.

(360) Bahari A, Aarabi M, Aarabi M, Hedayati M, Jarollahi A, Firouzi F, et al.

Diagnostic value of antineutrophil cytoplasmic antibodies and anti-Saccharomyces

cerevisiae antibody in Iranian patients with inflammatory bowel disease. Acta Gastro-

Enterol Belg 2009;72(3):301-305.

(361) Barzkar M, Pourhoseingholi MA, Habibi M, Moghimi-Dehkordi B, Safaee A,

Pourhoseingholi A, et al. Uninvestigated dyspepsia and its related factors in an Iranian

community. Saudi Med J 2009;30(3):397-402.

(362) Safaee A, Moghimi-Dehkordi B, Fatemi SR, Ghiasi S, Pourhoseingholi MA, Zali

MR. Clinicopathological features of gastric cancer: A study based on cancer registry

data. Iran J Cancer Prev 2009;2(2):67-70.

(363) Montazer Haghighi M, Radpour R, Aghajani K, Zali N, Molaei M, Zali MR. Four

novel germline mutations in the MLH1 and PMS2 mismatch repair genes in patients

with hereditary nonpolyposis colorectal cancer. Int J Colorectal Dis 2009;24(8):885-

893.

(364) Alebouyeh M, Behzadian-Nejad Q, Soleimani M, Hassan ZM, Salmanian AH,

Zali MR. Characterization of the interaction of undomesticated Bacillus subtilis spores

with Caco-2 cell line. Ann Microbiol 2009;59(2):273-277.

29

(365) Minakari M, Molaei M, Shalmani HM, Alizadeh AHM, Jazi AHD, Naderi N, et

al. Liver steatosis in patients with chronic hepatitis B infection: Host and viral risk

factors. Eur J Gastroenterol Hepatol 2009;21(5):512-516.

(366) Shavakhi A, Norinayer B, Esteghamat FS, Seghatoleslami M, Khodadustan M,

Somi MH, et al. Occult hepatitis B among Iranian hepatitis C patients. J Res Med Sci

2009;14(1):13-17.

(367) Moghimi-Dehkordi B, Safaee A, Ghiasi S, Zali MR. Survival in gastric cancer

patients: univariate and multivariate analysis. East Afr J Public Health 2009;6

Suppl(1):41-44.

(368) Pourhoseingholi A, Pourhoseingholi MA, Vahedi M, Moghimi-Dehkordi B,

Maserat AS, Zali MR. Relation between demographic factors and hospitalization in

patients with gastrointestinal disorders, using quantile regression analysis. East Afr J

Public Health 2009;6 Suppl(1):45-47.

(369) Kaboli SA, Zojaji H, Mirsattari D, Talaie R, Derakhshan F, Zali MR, et al. Effect

of addition of vitamin C to clarithromycin-amoxicillin-omeprazol triple regimen on

Helicobacter pylori eradication. Acta Gastro-Enterol Belg 2009;72(2):222-224.

(370) Pourhoseingholi MA, Dezfoulian A, Nasiri M, Dabiri H, Zali MR. Bayesian

sample size determination for the accurate identification of the bacterial subtypes. East

Afr J Public Health 2009;6 Suppl(1):37-38.

(371) Pourhoseingholi MA, Moghimi-Dehkordi B, Safaee A, Hajizadeh E, Solhpour A,

Zali MR. Prognostic factors in gastric cancer using log-normal censored regression

mode. Indian J Med Res 2009;129(3):262-267.

(372) Pourhoseingholi MA, Faghihzadeh S, Hajizadeh E, Abadi A, Zali MR. Bayesian

estimation of colorectal cancer mortality in the presence of misclassification in Iran.

Asian Pac J Cancer Preven 2009;10(4):691-694.

(373) Jafari F, Hamidian M, Rezadehbashi M, Doyle M, Salmanzadeh-ahrabi S,

Derakhshan F, et al. Prevalence and antimicrobial resistance of diarrheagenic

Escherichia coli and Shigella species associated with acute diarrhea in Tehran, Iran.

Can J Infect Dis Med Microbiol 2009;20(3):e56-e62.

(374) Haghighi MM, Vahedi M, Mohebbi SR, Pourhoseingholi MA, Fatemi SR, Zali

MR. Comparison of survival between patients with hereditary non-polyposis colorectal

cancer (HNPCC) and sporadic colorectal cancer. Asian Pac J Cancer Preven

2009;10(2):209-212.

(375) Jafari F, Garcia-Gil LJ, Salmanzadeh-Ahrabi S, Shokrzadeh L, Aslani MM,

Pourhoseingholi MA, et al. Diagnosis and prevalence of enteropathogenic bacteria in

children less than 5 years of age with acute diarrhea in Tehran children's hospitals. J

Infect 2009;58(1):21-27.

(376) Maserat E, Fatemi R, Zali MR. New perspective for integrated information

management in national colorectal cancer screening in Iran. Asian Pac J Cancer Preven

2009;10(4):701-706.

(377) Dallal MMS, Taremi M, Gachkar L, Modarressi S, Sanaei M, Bakhtiari R, et al.

Characterization of antibiotic resistant patterns of salmonella serotypes isolated from

beef and chicken samples in Tehran. Jundishapur J Microbiol 2009;2(4):124-131.

(378) Khatami F, Noorinayer B, Mohebi SR, Ghiasi S, Hashemi M, Zali MR. Effects of

amino acid substitution polymorphisms of two DNA methyltransferases on

31

susceptibility to sporadic colorectal cancer. Asian Pac J Cancer Preven

2009;10(6):1183-1188.

(379) Moghimi-Dehkordi B, Safaee A, Zali M. Comparison of colorectal and gastric

cancer: Survival and prognostic factors. Saudi J Gastroenterol 2009;15(1):18-23.

(380) Kharaziha P, Hellström PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F, et

al. Improvement of liver function in liver cirrhosis patients after autologous

mesenchymal stem cell injection: A phase I-II clinical trial. Eur J Gastroenterol Hepatol

2009;21(10):1199-1205.

(381) Khatami F, Noorinayer B, Ghiasi S, Mohebi R, Hashemi M, Zali MR. Lack of

effects of single nucleotide polymorphisms of the DNA methyltransferase 1 gene on

gastric cancer in Iranian patients: A case control study. Asian Pac J Cancer Preven

2009;10(6):1177-1182.

(382) Talaie R, Haydari Monfared M, Zojaji H, Dadashzadeh N, Reza Zali M,

Sheikhvatan M. Effects of sedation during upper gastrointestinal endoscopy on arterial

oxygen saturation. Hepato-Gastroenterology 2009;56(89):158-161.

(383) Haghighi MM, Vahedi M, Mohebbi SR, Pourhoseingholi MA, Fatemi SR, Zali

MR. Comparison of survival between patients with hereditary non polyposis colorectal

cancer (HNPCC) and sporadic colorectal cancer. Asian Pac J Cancer Preven

2009;10(3):497-500.

(384) Dabiri H, Maleknejad P, Yamaoka Y, Feizabadi MM, Jafari F, Rezadehbashi M,

et al. Distribution of Helicobacter pylori cagA, cagE, oipA and vacA in different major

ethnic groups in Tehran, Iran. J Gastroenterol Hepatol 2009;24(8):1380-1386.

(385) Pourhoseingholi MA, Vahedi M, Moghimi-Dehkordi B, Pourhoseingholi A,

Ghafarnejad F, Maserat E, et al. Burden of hospitalization for gastrointestinal tract

cancer patients - Results from a cross-sectional study in Tehran. Asian Pac J Cancer

Preven 2009;10(1):107-110.

(386) Molaei M, Pejhan S, Nayer BN, Moradi A, Ghiasi S, Zali MR. Human epidermal

growth factor receptor-2 family in colorectal adenocarcinoma: Correlation with survival

and clinicopathological findings. Eur J Gastroenterol Hepatol 2009;21(3):289-293.

(387) Reza F, AmirH MA, Faramarz D, Shahrokh M, Mehrdad Z, Shivarani S, et al.

Colorectal stenting for management of acute malignant bowel obstruction in advanced

colorectal cancer in iran. Asian Pac J Cancer Preven 2009;10(5):739-742.

(388) Alizadeh AHM, Ansari S, Ranjbar M, Shalmani HM, Habibi I, Firouzi M, et al.

Seroprevalence of Helicobacter pylori in Nahavand: A population-based study. East

Mediterr Health J 2009;15(1):129-135.

(389) Dabiri H, Maleknejad P, Yamaoka Y, Feizabadi MM, Jafari F, Rezadehbashi M,

et al. Erratum: Distribution of Helicobacter pylori cagA, cagE, oipA and vacA in

different major ethnic groups in Tehran, Iran (Journal of Gastroenterology and

Hepatology 24 (1380-1386) DOI: 10.1111/j.1440-1746.2009.05876.x). J Gastroenterol

Hepatol 2009;24(10):1700.

(390) Rostami Nejad M, Nazemalhosseini Mojarad E, Nochi Z, Fasihi Harandi M,

Cheraghipour K, Mowlavi GR, et al. Echinococcus granulosus strain differentiation in

Iran based on sequence heterogeneity in the mitochondrial 12S rRNA gene. J

Helminthol 2008;82(4):343-347.

31

(391) Mohebbi SR, Zali N, Derakhshan F, Tahami A, Mashayekhi R, Amini-Bavil-

Olyaee S, et al. Molecular epidemiology of Hepatitis Delta Virus (HDV) in Iran: A

preliminary report. J Med Virol 2008;80(12):2092-2099.

(392) Mirzaee V, Molaei M, Shalmani HM, Zali MR. Helicobacter pylori infection and

expression of DNA mismatch repair proteins. World J Gastroenterol 2008;14(43):6717-

6721.

(393) Foroutan M, Rahimi N, Tabatabaeifar M, Darvishi M, Hashemi M, Hossein-

panah F, et al. Clinical features of colorectal cancer in Iran: A 15-year review. J Dig

Dis 2008;9(4):225-227.

(394) Sharifi F, Esmaeilzadeh A, Zali M. Hemochromatosis gene (HFE) mutations in

patients with type 2 diabetes and their control group in an Iranian population. Saudi

Med J 2008;29(6):808-812.

(395) Jafari F, Shokrzadeh L, Hamidian M, Salmanzadeh-Ahrabi S, Zali MR. Acute

diarrhea due to enteropathogenic bacteria in patients at hospitals in Tehran. Jpn J Infect

Dis 2008;61(4):269-273.

(396) Jafari F, Shokrzadeh L, Dabiri H, Baghaei K, Yamaoka Y, Zojaji H, et al. vacA

genotypes of Helicobacter pylori in relation to cagA status and clinical outcomes in

Iranian populations. Jpn J Infect Dis 2008;61(4):290-293.

(397) Solhpour A, Pourhoseingholi MA, Soltani F, Zarghi A, Solhpour A, Habibi M, et

al. Gastro-oesophageal reflux disease and irritable bowel syndrome: A significant

association in an Iranian population. Eur J Gastroenterol Hepatol 2008;20(8):719-725.

(398) Solhpour A, Pourhoseingholi MA, Soltani F, Zarghi A, Habibi M, Ghafarnejad F,

et al. Gastro-esophageal reflux symptoms and body mass index: No relation among the

Iranian population. Indian J Gastroenterol 2008;27(4):153-155.

(399) Moghimi-Dehkordi B, Safaee A, Zali MR. Prognostic factors in 1,138 Iranian

colorectal cancer patients. Int J Colorectal Dis 2008;23(7):683-688.

(400) Masoodi M, Aghazadeh R, Somi MH, Shavakhi A, Shabestari AA, Zali MR.

Serum insulin-like growth factor-I and tumor size in patients with metastatic liver

cancer. Hepatitis Mon 2008;8(3):179-183.

(401) Rezailashkajani M, Roshandel D, Shafaee S, Zali MR. A cost analysis of gastro-

oesophageal reflux disease and dyspepsia in Iran. Dig Liver Dis 2008;40(6):412-417.

(402) Saniei M, Mehr EJ, Shahraz S, Zahedi LN, Rad AM, Sayar S, et al. Prenatal

screening and counseling in iran and ethical dilemmas. Community Genet

2008;11(5):267-272.

(403) Madani S, Noorinayer B, Madani H, Sadrolhefazi B, Molanayee S, Bakayev V, et

al. No association between TNF-α-238 polymorphism and colorectal cancer in Iranian

patients. Acta Oncol 2008;47(3):473-474.

(404) Foroutan M, Doust HM, Jodeiri B, Derakhshan F, Mohaghegh H, Mousapour H,

et al. Relevance of ineffective esophageal motility with erosive and nonerosive

gastroesophageal reflux disease. Indian J Gastroenterol 2008;27(2):58-61.

(405) Akhoondi S, Sun D, Von Der Lehr N, Apostolidou S, Klotz K, Maljukova A, et

al. FBXW7/hCDC4 is a general tumor suppressor in human cancer (Cancer Research

(October 2007) 67 (9006-9012)). Cancer Res 2008;68(4):1245.

32

(406) Rezailashkajani M, Roshandel D, Ansari S, Zali MR. A web-based patient

education system and self-help group in Persian language for inflammatory bowel

disease patients. Int J Med Informatics 2008;77(2):122-128.

(407) Minakari M, Sameni FK, Shalmani HM, Molaee M, Zali M-. Hepatic steatosis in

Iranian patients with chronic hepatitis C. Med Princ Pract 2008;17(2):126-130.

(408) Haghighi MM, Mohebbi SR, Sadeghi RN, Vahedi M, Ghiasi S, Zali MR.

Association between the 1793G>A MTHFR polymorphism and sporadic colorectal

cancer in Iran. Asian Pac J Cancer Preven 2008;9(4):659-662.

(409) Moghimi-Dehkordi B, Safaee A, Pourhoseingholi MA, Fatemi R, Tabeie Z, Zali

MR. Statistical comparison of survival models for analysis of cancer data. Asian Pac J

Cancer Preven 2008;9(3):417-420.

(410) Moghimi-Dehkordi B, Safaee A, Pourhoseingholi MA, Zali MR. Effect of

demographic and clinicopathologic factors on prognosis of early gastric cancer in Iran.

Asian Pac J Cancer Preven 2008;9(4):585-588.

(411) Pourhoseingholi A, Pourhoseingholi MA, Vahedi M, Safaee A, Moghimi-

Dehkordi B, Ghafarnejad F, et al. Relation between demographic factors and type of

gastrointestinal cancer using probit and logit regression. Asian Pac J Cancer Preven

2008;9(4):753-755.

(412) Taremi M, Mohammad Alizadeh AH, Ardalan A, Ansari S, Zali MR.

Seroprevalence of hepatitis E in Nahavand, Islamic Republic of Iran: A population-

based study. East Mediterr Health J 2008;14(1):157-162.

(413) Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Noorinayer B, Derakhshan F,

Chiani M, et al. Molecular epidemiology of hepatitis B virus in Iran. Clin Microbiol

Infect 2008;14(9):858-866.

(414) Derakhshan F, Naderi N, Farnood A, Firouzi F, Habibi M, Rezvany MR, et al.

Frequency of three common mutations of CARD15/NOD2 gene in Iranian IBD

patients. Indian J Gastroenterol 2008;27(1):8-11.

(415) Naderi N, Farnood A, Habibi M, Derakhshan F, Balaii H, Motahari Z, et al.

Association of vitamin D receptor gene polymorphisms in Iranian patients with

inflammatory bowel disease. J Gastroenterol Hepatol 2008;23(12):1816-1822.

(416) Azadeh S, Moghimi-Dehkordi B, Fatemi SR, Pourhoseingholi MA, Ghiasi S, Zali

MR. Colorectal cancer in Iran: An epidemiological study. Asian Pac J Cancer Preven

2008;9(1):123-126.

(417) Khoshbaten M, Khorram H, Madad L, Ehsani Ardakani MJ, Farzin H, Zali MR.

Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography

pancreatitis. J Gastroenterol Hepatol 2008;23(7 PT2):e11-e16.

(418) Moghimi-Dehkordi B, Safaee A, Zali MR. Survival rates and prognosis of gastric

cancer using an actuarial life-table method. Asian Pac J Cancer Preven 2008;9(2):317-

322.

(419) Firouzi F, Rashidi M, Hashemi S, Kangavari M, Bahari A, Daryani NE, et al. A

decision tree-based approach for determining low bone mineral density in inflammatory

bowel disease using WEKA software. Eur J Gastroenterol Hepatol 2007;19(12):1075-

1081.

(420) Khorramizadeh MR, Soltan-Dallal MM, Safavifar F, Saadat F, Rezaie S,

Hashemi S, et al. Assessment of ail gene marker amplicon for molecular

33

characterization of pathogenic Yersinia enterocolitica in food samples collected in Iran.

Iran J Public Health 2007;36(3):8-15.

(421) Shavakhi A, Khodadustan M, Zafarghandi M, Gachkar L, Firozi M, Ardakani

MJE, et al. Seroprevalence of anti-helicobacter pylori antibodies in hepatitis B and C

patients with cirrhosis: A case-control study. J Res Med Sci 2007;12(6):293-297.

(422) Akhoondi S, Sun D, Von Der Lehr N, Apostolidou S, Klotz K, Maljukova A, et

al. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res

2007;67(19):9006-9012.

(423) Feizabadi MM, Dolatabadi S, Zali MR. Isolation and drug-resistant patterns of

Campylobacter strains cultured from diarrheic children in Tehran. Jpn J Infect Dis

2007;60(4):217-219.

(424) Farnood A, Naderi N, Moghaddam SJM, Noorinayer B, Firouzi F, Aghazadeh R,

et al. The frequency of C3435T MDR1 gene polymorphism in Iranian patients with

ulcerative colitis. Int J Colorectal Dis 2007;22(9):999-1003.

(425) Roshandel D, Rezailashkajani M, Shafaee S, Zali MR. A cost analysis of

functional bowel disorders in Iran. Int J Colorectal Dis 2007;22(7):791-799.

(426) Hosseini HA, Ahani A, Galehdari H, Froughmand AM, Hosseini M,

Masjedizadeh A, et al. Frequent loss of heterozygosity at 8p22 chromosomal region in

diffuse type of gastric cancer. World J Gastroenterol 2007;13(24):3354-3358.

(427) Farahtaj F, Gallimore CI, Iturriza-Gomara M, Taremi M, Zali MR, Edalatkhah H,

et al. Rotavirus VP7, VP4 and VP6 genotypes co-circulating in Tehran, Iran, between

2003 and 2004. Epidemiol Infect 2007;135(5):834-838.

(428) Rezailashkajani M, Roshandel D, Shafaee S, Zali MR. High prevalence of reflux

oesophagitis among upper endoscopies of Iranian patients. Eur J Gastroenterol Hepatol

2007;19(6):499-506.

(429) Alizadeh AHM, Behrouz N, Salmanzadeh S, Ranjbar M, Azimian MH, Habibi E,

et al. Escherichia coli, Shigella and Salmonella species in acute diarrhoea in Hamedan,

Islamic Republic of Iran. East Mediterr Health J 2007;13(2):243-249.

(430) Alidoust L, Zafarghandi M, Agah M, Sendi H, Alavian SM, Zali MR.

Glutathione-S-transferase M1, T1 and P1 gene polymorphisms in type I autoimmune

hepatitis: A case-control study [3]. Indian J Gastroenterol 2007;26(2):97-99.

(431) Ghaziani T, Alavian S-, Zali MR, Shahraz S, Agah M, Jensen KP, et al. Serum

measures of iron status and HFE gene mutations in patients with hepatitis B virus

infection. Hepatol Res 2007;37(3):172-178.

(432) Moghaddam SJ, Haghighi EN, Samiee S, Shahid N, Keramati AR, Dadgar S, et

al. Immunohistochemical analysis of p53, cyclinD1, RB1, c-fos and N-ras gene

expression in hepatocellular carcinoma in Iran. World J Gastroenterol 2007;13(4):588-

593.

(433) Pourhoseingholi MA, Hajizadeh E, Dehkordi BM, Safaee A, Abadi A, Zali MR.

Comparing cox regression and parametric models for survival of patients with gastric

Carcinoma. Asian Pac J Cancer Preven 2007;8(3):412-416.

(434) Salmanzadeh-Ahrabi S, Jafari F, Habibi E, Irajian GR, Aslani MM, Baghbani-

Arani F, et al. Short communication: Serotype distribution and antimicrobial resistance

rates of Shigella spp. isolates in Tehran, Iran. Mikrobiyol Bulteni 2007;41(3):453-457.

34

(435) Somi MH, Najafi L, Noori N B, Alizadeh AHM, Aghah MR, Shavakhi A, et al.

Tumor necrosis factor-alpha gene promoter polymorphism in Iranian patients with

chronic hepatitis B. Indian J Gastroenterol 2006;25(1):14-15.

(436) Zali M, Bahari A, Firouzi F, Daryani NE, Aghazadeh R, Emam MM, et al. Bone

mineral density in Iranian patients with inflammatory bowel disease. Int J Colorectal

Dis 2006;21(8):758-766.

(437) Roshandel D, Rezailashkajani M, Shafaee S, Zali MR. Symptom patterns and

relative distribution of functional bowel disorders in 1,023 gastroenterology patients in

Iran. Int J Colorectal Dis 2006;21(8):814-825.

(438) Alizadeh AHM, Fallahian F, Alavian SM, Ranjbar M, Hedayati M, Rahimi F, et

al. Insulin resistance in chronic hepatitis B and C. Indian J Gastroenterol

2006;25(6):286-289.

(439) Masjedizadeh R, Hajiani E, MoezArdalan K, Samie S, Ehsani-Ardakani M-,

Daneshmand A, et al. H pylori infection and reflux oesophagitis: A case-control study.

World J Gastroenterol 2006;12(35):5658-5662.

(440) Alizadeh AHM, Ranjbar M, Ansari S, MirArab A, Alavian SM, Mohammad K, et

al. Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran. East Mediterr

Health J 2006;12(5):528-537.

(441) Zali M-, Mohammad K, Noorbala A-, Noorimayer B, Sahraz S. Erratum: Rate of

hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran

(Eastern Mediterranean Health Journal (2005) vol. 11 (1/2) (62-67)). East Mediterr

Health J 2006;12(5):678.

(442) Vejdani R, Shalmani HRM, Mir-Fattahi M, Sajed-Nia F, Abdollahi M, Zali MR,

et al. The efficacy of an herbal medicine, Carmint, on the relief of abdominal pain and

bloating in patients with irritable bowel syndrome: A pilot study. Dig Dis Sci

2006;51(8):1501-1507.

(443) Rezailashkajani M, Roshandel D, Ansari S, Zali MR. Knowledge of disease and

health information needs of the patients with inflammatory bowel disease in a

developing country. Int J Colorectal Dis 2006;21(5):433-440.

(444) Taremi M, Mehdi Soltan Dallal M, Gachkar L, MoezArdalan S, Zolfagharian K,

Reza Zali M. Prevalence and antimicrobial resistance of Campylobacter isolated from

retail raw chicken and beef meat, Tehran, Iran. Int J Food Microbiol 2006;108(3):401-

403.

(445) Mohammed Alizadeh AH, Fatemi SR, Mirzaee V, Khoshbaten M, Talebipour B,

Sharifian A, et al. Clinical features of hepatopulmonary syndrome in cirrhotic patients.

World J Gastroenterol 2006;12(12):1954-1956.

(446) Firouzi F, Bahari A, Aghazadeh R, Zali MR. Appendectomy, tonsillectomy, and

risk of inflammatory bowel disease: A case control study in Iran. Int J Colorectal Dis

2006;21(2):155-159.

(447) Shahmoradgoli M, Mueller O, Kutzner N, Noorinayer B, Zali MR. Gene symbol:

APC. Disease: Familial adenomatous polyposis coli. Accession #Hd0518. Hum Genet

2006;118(6):776.

(448) Mohammadzadeh Ghobadloo S, Yaghmaei B, Allameh A, Hassani P, Noorinayer

B, Reza Zali M. Polymorphisms of glutathione S-transferase M1, T1, and P1 in patients

with HBV-related liver cirrhosis, chronic hepatitis, and normal carriers. Clin Biochem

2006;39(1):46-49.

35

(449) Masoodi M, Zali M-, Ehsani-Ardakani M-, Mohammad-Alizadeh A-, Aiassofi K,

Aghazadeh R, et al. Abdominal pain due to lead-contaminated opium: A new source of

inorganic lead poisoning in Iran. Arch Iran Med 2006;9(1):72-75.

(450) Taremi M, Khoshbaten M, Gachkar L, EhsaniArdakani M, Zali M. Hepatitis E

virus infection in hemodialysis patients: a seroepidemiological survey in Iran. BMC

Infect Dis 2005;5.

(451) Sendi H, Mehrab-Mohseni M, Zali MR, Norder H, Magnius LO. T1764G1766

core promoter double mutants are restricted to Hepatitis B virus strains with an A1757

and are common in genotype D. J Gen Virol 2005;86(9):2451-2458.

(452) Alizadeh AHM, Ranjbar M, Ansari S, Alavian SM, Shalmani HM, Hekmat L, et

al. Intra-familial prevalence of hepatitis B virologic markers in HBsAg positive family

members in Nahavand, Iran. World J Gastroenterol 2005;11(31):4857-4860.

(453) Roshandel D, Rezailashkajani M, Ansari S, Zali MR. Internet use by a referral

gastroenterology clinic population and their medical information preferences. Int J Med

Informatics 2005;74(6):447-459.

(454) Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Adeli A, Mahboudi F, Sabahi F,

Nafisi H, et al. A novel accurate amplification created restriction site method for

determination of the wild type and the precore mutant hepatitis B virus variants. J Virol

Methods 2005;127(1):19-23.

(455) Esteghamat F, Noorinayer B, Sanati MH, Hekmatdoost A, Zafarghandi M,

Shalmani HM, et al. C77G mutation in protein tyrosine phosphatase CD45 gene and

autoimmune hepatitis. Hepatol Res 2005;32(3):154-157.

(456) Taremi M, Khoshbaten M, Gachkar L, Ehsani Ardakani MJ, Zali MR. Hepatitis E

virus infection in hemodialysis patients: A seroepidemiological survey in Iran. BMC

Infect Dis 2005;5.

(457) Honarkar Z, Alavian SM, Samiee S, Saeedfar K, Zali MR. Occult hepatitis B

among chronic liver disease patients. Saudi Med J 2005;26(4):601-606.

(458) Alavian S-, Adibi P, Zali M-. Hepatitis C virus in Iran: Epidemiology of an

emerging infection. Arch Iran Med 2005;8(2):84-90.

(459) Salmanzadeh-Ahrabi S, Habibi E, Jaafari F, Zali M-. Molecular epidemiology of

Escherichia coli diarrhoea in children in Tehran. Ann Trop Paediatr 2005;25(1):35-39.

(460) Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Mahboudi F, Sabahi F, Adeli A,

Noorinayer B, et al. Genotype characterization and phylogenetic analysis of hepatitis B

virus isolates from Iranian patients. J Med Virol 2005;75(2):227-234.

(461) Sendi H, Ghaziani T, Zali MR, Adibi P, Agah M, Jazayeri M, et al.

Hemochromatosis mutations in Iranians with Hepatitis B virus infection. Clin Infect

Dis 2005;40(3):e19-e21.

(462) Slim R, Fallahian M, Rivière J-, Zali MR. Evidence of a genetic heterogeneity of

familial hydatidiform moles. Placenta 2005;26(1):5-9.

(463) Zali M-, Mohammad K, Noorbala A-, Noorimayer B, Sahraz S. Rate of hepatitis

B seropositivity following mass vaccination in the Islamic Republic of Iran. East

Mediterr Health J 2005;11(1-2):62-67.

(464) Aghazadeh R, Zali MR, Bahari A, Amin K, Ghahghaie F, Firouzi F.

Inflammatory bowel disease in Iran: A review of 457 cases. J Gastroenterol Hepatol

2005;20(11):1691-1695.

36

(465) Zali MR, Mehr AJ, Rezaian M, Meamar AR, Vaziri S, Mohraz M. Prevalence of

intestinal parasitic pathogens among HIV-positive individuals in Iran. Jpn J Infect Dis

2004;57(6):268-270.

(466) Hekmatdoost A, Ghaziani T, Esteghamathanzaie F, Alavian S, Mohaghegh H,

Zali M. Transfusion transmitted virus and autoimmune hepatitis. Is there any

association? Saudi Med J 2004;25(11):1760-1761.

(467) Adibi P, Ghassemian R, Alavian S-, Ranjbar M, Mohammadalizadeh AH,

Nematizadeh F, et al. Effectiveness of hepatitis B vaccination in children of chronic

hepatitis B mothers. Saudi Med J 2004;25(10):1414-1418.

(468) Ghaffarzadegan K, Zali M-, Jami-Ahmadi K, Asadzadeh H, Abbaszadegan M-.

Correlation of nuclear p53 immunoreaction with the histopathologic features in gastric

carcinoma. Arch Iran Med 2004;7(4):279-283.

(469) Adibi P, Rezailashkajani M, Roshandel D, Behrouz N, Ansari S, Somi MH, et al.

An economic analysis of premarriage prevention of hepatitis B transmission in Iran.

BMC Infect Dis 2004;4.

(470) Zali MR, Ghaziani T, Shahraz S, Hekmatdoost A, Radmehr A. Liver, spleen,

pancreas and kidney involvement by human fascioliasis: Imaging findings. BMC

Gastroenterol 2004;4.

(471) Aghazadeh R, Zali M-, Bahari A, Amin K, Ghahghaie F, Firouzi F. Inflammatory

bowel disease in Iran: A review of 448 cases. Arch Iran Med 2004;7(3):210-216.

(472) Ghobadloo SM, Yaghmaei B, Bakayev V, Goudarzi H, Noorinayer B, Rad FH, et

al. GSTP1, GSTM1, and GSTT1 genetic polymorphisms in patients with cryptogenic

liver cirrhosis. J Gastrointest Surg 2004;8(4):423-427.

(473) Mehr AJ, Ardakani MJE, Hedayati M, Shahraz S, Mehr EJ, Zali MR. Age-

specific seroprevalence of hepatitis A infection among children visited in pediatric

hospitals of Tehran, Iran. Eur J Epidemiol 2004;19(3):275-278.

(474) Masoodi M, Reza Zali M, Aghazadeh R, Alizadeh AHM, Ardakani MJE,

Shabestari AA, et al. Cholecystocolic fistula due to adenocarcinoma of the colon. Eur J

Radiol Extra 2004;50(3):97-99.

(475) Bakayev V, Ignatiev I, Jazayeri M, Mohaghegh H, Zborovsky S, Zali MR.

Duplex polymerase chain reaction-restriction fragment length polymorphism assay for

rapid detection of HFE mutations - C282Y occurs with a low frequency in Tehran's

population [1]. J Hepatol 2004;40(3):559-560.

(476) Jazayeri M, Bakayev V, Adibi P, Rad FH, Zakeri H, Kalantar E, et al. Frequency

of HFE gene mutations in Iranian beta-thalassaemia minor patients. Eur J Haematol

2003;71(6):408-411.

(477) Shahraz S, Sherafat-Kazemzadeh R, Zali M-. The boundaries of health system: A

proposed model. Arch Iran Med 2003;6(4):243-250.

(478) MoezArdalan K, Reza Zali M, Soltan Dallal MM, Hemami MR, Salmanzadeh-

Ahrabi S. Prevalence and pattern of antimicrobial resistance of Shigella species among

patients with acute diarrhoea in Karaj, Tehran, Iran. J Health Popul Nutr 2003;21(2):96-

102.

(479) Sherafat-Kazemzadeh R, Shahraz S, Mohaghegh-Shalmani H, Ghaziani T,

Faghahati L, Zali M-, et al. Iranian persons living with HIV/AIDS unveil the epidemic

37

of stigma (An overview of patients' attitudes towards the disease and community in first

GIPA gathering in Tehran). Arch Iran Med 2003;6(2):77-80.

(480) Zali MR, Shahraz S, Borzabadi S. Bioethics in Iran: Legislation as the main

problem. Arch Iran Med 2002;5(3):136-140.

(481) Nobakht-Haghighi A, Zali M-, Mahdavi M-, Nowroozi A. Malpractice claims: A

preliminary study in Tehran. Arch Iran Med 2002;5(1):52-53.

(482) Zali MR, Mayumi M, Raoufi M, Nowroozi A. Hepatitis C virus genotypes in the

Islamic Republic of Iran: A preliminary study. East Mediterr Health J 2000;6(2-3):372-

377.

(483) Zali MR, Mayumi M, Raoufi M, Nowroozi A. GBV-C infection among patients

with hepatitis C virus in the Islamic Republic of Iran: A preliminary report. East

Mediterr Health J 1999;5(5):1030-1034.

(484) Seyedein SM, Zali MR, Golpaigani MV, Yazdani H, Nourhalouchi S. Oral health

survey in 12-year-old children in the Islamic Republic of Iran, 1993-1994. East

Mediterr Health J 1998;4(2):338-342.

(485) Sawant P, Upadhyay AP, Levicnik-Stezinar S, Zali MR, Okamoto H. Genotypes

of GB virus C and hepatitis C virus in hepatitis patients in India, Iran and Slovenia.

Hepatol Res 1998;10(2):175-183.

(486) Zali MR, Mohammad K, Farhadi A, Masjedi MR, Zargar A, Nowroozi A.

Epidemiology of hepatitis B in the Islamic Republic of Iran. East Mediterr Health J

1996;2(2):290-298.

Domestic

1. Shavakhi A, Esteghamat F, Sharifian A, Mohamad Alizade AH, Khodadostan

M, Somi MH, Antikchi MH, Masoodi M, Firozi M, Khodadustan M, Zali MR.

Evaluation of Hepatitis E in Cirrhotic Patients, A Case Control Study Govaresh, Iranian Association of Gastroenterology And

Hepatology 2007;1(12): 27-29

2. Naderi N, Farnood A, Habibi M, Derakhshan F, Motahari Z, Agah MR, Vali

Khojeini E, Balaii H, Zojaji H, Ghaffarzadeh Rad M, Aghazadeh R, Ebrahimi

Daryani N, Noorinayer B, Zali MR. Association of the Vitamin D Receptor

Gene Polymorphisms with Inflammatory Bowel Disease in Iran Govaresh, Iranian Association of Gastroenterology And

Hepatology 2006;3(11): 150-157

3. Honarkar Z, Baladast M, Ehsani Ardakani MJ, Jodeiri B, Seyedi Sh, Zali MR.

Gastrin, Cholecystokinin (CCK) and H. Pylori in Nonulcer Dyspepsia Shiraz E Medical Journal 2007;1(8): 13-21

4. M.J. Ehsani Ardakani, M. Foroutan, N. Amani, I. Neshandar Asli, M.

Hosseinnezhad Yazdi, A. Yousefi, H. Mohaghegh Shalmani, M. Baladast, M.

Naseri, M.R. Zali. Esophageal Transit Scintigraphy, Manometry, and

Barium Swallow in Assessment of Response to Balloon Dilatation in

Achalasia. IRANIAN JOURNAL OF RADIOLOGY 2006;1(4): 1-6

38

5. Maleki I, Nouri Nayer B, Najm Abadi H, Zali MR. Novel mutations of

Wilson's disease ATP7B gene in Iranian patients. MEDICAL JOURNAL OF

MAZANDARAN 2006;1(1): 30-28

6. Ali Doost L, Zafar Ghandi M, Agah MR, Sandi H, Zali MR. Glutathion-S-

Transferase M1, T1 and P1 gene polymorphisms in autoimmune Hepatitis.

JOURNAL OF THE SHAHEED BEHESHTI UNIVERSITY OF MEDICAL

SCIENCES AND HEALTH SERVICES 2006;2(30): 167-161

7. Somi MH, Jodeiri B, Zali MR Clinical presentation and epidemiologic

findings in Achalasia. MEDICAL JOURNAL OF TABRIZ UNIVERSITY OF

MEDICAL SCIENCES & HEALTH SERVICES 2006;1(28): 97-93

8. Mohammad Ali Zadeh AH, Reza Zadeh M, Ranjbar M, Fallahian F, Haji Looei

M, Mousavi SM, Abbasi M, Zali MR. Frequencies of Hepatitis B and C

infections in Hemophiliacs of Hamedan province, 2004. JOURNAL OF THE

SHAHEED BEHESHTI UNIVERSITY OF MEDICAL SCIENCES AND

HEALTH SERVICES 2006;2(30): 123-119

9. Ehsani Ardakani MJ, Mohaghegh Shalmani H, Nemati E, Zali MR. Frequency

of Helicobacter Pylori among patients with diabetes mellitus JOURNAL OF

THE SHAHEED BEHESHTI UNIVERSITY OF MEDICAL SCIENCES AND

HEALTH SERVICES 2006;2(30): 106-103.

10. Farnood A, Naderi N, Noori Nayer B, Mirhasani-Moghaddam J, Firouzi F,

Aghazadeh R, Ebrahimi Daryani N, Zali M R. The Frequency of C3435T

MDR1 Gene Polymorphism in Iranian Patients with Ulcerative Colitis.

Journal of The Faculty of Medicine of Shaheed Beheshti university of Medical

Sciences May 2006 , Vol 30 No 1

11. Feyzabadi MM, Dolatabadi S, Salmanzadeh Ahrabi S, Moezardalan S, Jarollahi

A, Zali M R. Isolation, Identification and Drug Susceptibility Patterns of

Campylobacter Strains Cultured from Children with Diarrhea at two

Pediatric Hospitals in Tehran, 2003-2004. Journal of The Faculty of Medicine

of Shaheed Beheshti university of Medical Sciences November 2005 , Vol 29

No 3

12. Farnood A, Naderi N, Firouzi F, Rezvani MR, Javeri A, Bahari A, Aghazadeh

R, Habibi M, Zali M R. The Frequency of Three Common Mutations of

CARD15/NOD2 Gene in Iranian IBD Patients. Medical Sciences Journal of

Islamic Azad University Tehran Medical Unit November 2005 , Vol 15 No 3

13. Mohammad Alizadeh AH, Salmanzadeh Ahrabi S, Ranjbar M, Behrouz N,

Azaimian MH, Ejmalian S, Dorouzi T, Rabie Yeganeh M, Chavoshi A, Zali M

R. Frequency of E-coli, Shigella, Salmonella and their Strains in Acute

Diarrhea in Hamedan, Summer 2003. Pajouhandeh Sep-Oct 2005 , Vol

10 No 4

39

14. Agah MR, Sendi H, Zafarghandi M, Ghaziani T, Aryapad A, Hekmatdoost A,

Zali M R. Association between HFE Gene Mutations and Autoimmune

Hepatitis. Pajouhandeh Sep-Oct 2005 , Vol 10 No 4

15. Agah MR, Zafarghandi M, Motahari Z, Jazaeri H, Hajibeigi B, Attarchy Z,

Rajabi T, Zali M R. Frequency and Biochemical Expression of

Hemochromatosis (HFE) Gene Mutations in 1029 Blood Donors in Iran Medical Sciences Journal of Islamic Azad University Tehran Medical Unit

August 2005 , Vol 15 No 2

16. Fatemi SR, Mohammad Alizadeh AH, Mirzaie V, Khoshbaten M, Talebipour B,

Sharifran A, Khoram Z, Hajsheikholeslami F, Gholamreza Shirazi M, Zali M

R.Clinical and Diagnostic Characteristics of Hepatopulmonary Syndrome

among Iranian Patients with Cirrhosis. Journal of The Faculty of Medicine of

Shaheed Beheshti university of Medical Sciences August 2005 , Vol 29 No 2

17. Sherafat Kazemzadeh R, Shahraz S, Mohaghegh-Shalmani Hamid, Noori Nayer

B, Ansari Sh, Ghaziani M, Ghotbi H, Mohagheghi MA, Moosavi Jarrahi AR,

Gooya MM, Mirhassani Moghaddam SJ, Zali M R. Surveying the Primary

Liver Cancers Registered in Center of Disease Control and Institute of

Cancer of Iran, 1356- 79. Pajouhandeh May-Jun 2005 , Vol 10 No 2

18. Aghazadeh R, Mohammad Alizadeh AH, Ansari Sh, Ranjbar M, Hosseinnejad

Yazdi M, Honarkar Z, Baladast M, Mohaghegh Shalmani H, Belar N, Zali M

R.Epidemiology of Dyspepsia in Nahavand, Iran. Journal of The Faculty of

Medicine of Shaheed Beheshti university of Medical Sciences May 2005 ,

Vol 29 No 1

19. Ehsani Ardakani MJ, Forootan M, Amani N, Hossein nezhad yazdi M,

Neshandar Asli I, Mohaghegh-Shalmani Hamid, Zali M R. Erect Esophageal

Transit Scintigraphy, Manometry, and Barium Swallow in Assessment of

Patients with Achalasia before and after Balloon Dilation. Tabib_E_Shargh

February 2005 , Vol 6 No 4

41

20. Aghazadeh R, Hashemi B, Mohammad Alizadeh AH, Baladast M, Honarkar Z,

Ebtia M, Zali M R.Barrett's Esophagus in Patients Candidated for

Endoscopy. Journal of The Faculty of Medicine of Shaheed Beheshti university

of Medical Sciences February 2005 , Vol 28 No 4

21. Sendi H, Ghaziani T, Adibi P, Agah MR, Jazayeri M, Zali M R HFE

Mutations in Iranian Hepatitis B Virus Infected Patients. Journal of The

Faculty of Medicine of Shaheed Beheshti university of Medical Sciences

February 2005 , Vol 28 No 4

22. Mohraz M, Jafarimehr A, Rezaian M, Memar AR, Vaziri S, Moghaddam

Golmohammadi A, Zali M R. Prevalence of Intestinal Parasitic Pathogens

among HIV -Positive Individuals in Tehran and Kermansha, Iran. Journal

of The Faculty of Medicine of Shaheed Beheshti university of Medical Sciences

February 2005 , Vol 28 No 4

23. Mirhassani Moghaddam J, Zali M R, Taghizadeh F, Noroozi N, Narimani A,

Peyman S. MEFV Gene Mutations in Iranian Patients with Familial

Mediterranean Fever (FMF)) Journal of The Faculty of Medicine of Shaheed

Beheshti university of Medical Sciences February 2005 , Vol 28 No 4

24. Roshandel D, Rezai Lashkajani MR, Hekmatdoost A, Mohaghegh Shalmani H,

Ghaziani T, Sendi H, Alavian S M, Sherafat Kazemzadeh R, Sima HR, Zali M

R. Clinical Characteristics of Autoimmune Hepatitis Tabib_E_Shargh

February 2005 , Vol 6 No 4

25. Mirhassani Moghaddam SJ, Samiei S, Shahid N, Daneshmand MA, Nobakht

Haghighi E, Keramati AR, Zali M R. Immunohistochemical Analyses of

P53, Cyclin Dl, Rbl, C-Fos and N-Ras Genes Expression In Hepatocellular

Carcinoma in Iran. Journal of The Faculty of Medicine of Shaheed Beheshti

university of Medical Sciences November 2004 , Vol 28 No 3

26. Hekmatdoost A, Ghaziani T, Esteghamat F, Alavian S M, Mohaghegh Shalmani

H, Zali M R. TT virus infection in Iranian Patients with Autoimmune

Hepatitis and their Controls. Journal of The Faculty of Medicine of Shaheed

Beheshti university of Medical Sciences November 2004 , Vol 28 No 3

27. Adibi P, Rezailashkajani M, Roshandel D, Behrouz N, Ansari Sh, Somi MH,

Shahraz S, Zali M R. An Economic Analysis Of Premarriage Prevention Of

Hepatitis B Transmission In Iran. Journal of The Faculty of Medicine of

Shaheed Beheshti university of Medical Sciences November 2004 , Vol 28

No 3

28. Habibi E, Ghorbani Sh, Jarollahi ., Zali M R. Serotyping of Group A

Rotaviruses in Children Less than 7 Years Old in Tehran. Journal of The

Faculty of Medicine of Shaheed Beheshti university of Medical Sciences

November 2004 , Vol 28 No 3

29. Salmanzadeh Ahrabi S, Reai-Hemami M, Zali M R. Detection of Listeria

Monocytogenes in Milk by the Polymerase Chain Reaction. Journal of The

41

Faculty of Medicine of Shaheed Beheshti university of Medical Sciences

November 2004 , Vol 28 No 3

30. Neshandar-asl E, Jodeiri B, Baladast M, Ehsani Ardakani MJ, Shafiee B,

Honarkar Z, Valizadeh Toosi SM, Seyedi Sh, Zali M R. Influence Of

Helicobacter Pylori Infection On Gastric Emptying Ill Non-Ulcerative

Dyspeptic Patients. Journal of The Faculty of Medicine of Shaheed Beheshti

university of Medical Sciences November 2004 , Vol 28 No 3 31. Honarkar Z, Alavian S M, Samii SH, Saidfar K, Baladast M, Aghazadeh R, Zali

M R. Serological and Mulecular Evidences of Hepatitis B in Patients with

Chronic Hepatitis C. RAHAVARD- E DANESH May 2004 , Vol 7 No 1

32. Aghazadeh R, Zali MR, Bahari A, Kamyar A, Ghahghaie F, Firouzi F.

Inflammatory Bowel Disease in Iran: A Review of 448 Cases. Archives of

Iranian Medicine July 2004 , Vol 7 No 3

33. Vejdani R, Zali MR. Probiotics and their mechanism of action in the

prevention and treatment of human diseases. Journal of The Faculty of

Medicine of Shaheed Beheshti university of Medical Sciences February 2004

, Vol 27 No 4

34. Sherafat-Kazemzadeh R, Shahraz S, Mohaghegh-Shalmani H, Ghaziani T,

Faghahati L, Zali MR, Mohraz M. Iranian Persons Living with HIV / Aids

Unveil the Epidemic of Stigma (An Overview of Patients' Attitudes towards

the Disease and Community in first GIPA Gathering in Tehran). Archives

of Iranian Medicine April 2003 , Vol 6 No 2

35. Mirhassani Moghaddam SJ, Daneshmand MA, Aghakhani A, Edrissian MO,

Zali MR. P53 and Rb Genes Expression Changes in Esophageal Squamous

Cell Carcinoma in Iran. Scientific Journal of Isfahan University of Medical

Sciences and Health Services February 2003 , Vol 7 No 4

36. Maleki I, Genshel I, Golsorkhi H, Edalatkhah H, Mirfatahi M, Mohaghegh

Shalmani H, Schmidt H, Najm abadi H, Zali MR. Mutations in Patients with

Wilson Disease in Iran. Scientific Journal of Isfahan University of Medical

Sciences and Health Services February 2003 , Vol 7 No 4

37. Zali MR, Moez Ardalan K, Parcham Azad K, Nik-Kholgh B. Etiologies of

Acute Diarrheal Diseases in Iran. Scientific Journal of Isfahan University of

Medical Sciences and Health Services February 2003 , Vol 7 No 4

38. Bakayev VV, Zborovsky SS, Ignatiev IV, Jazayeri M, Zali MR. Developing of

Multiplex PCR and RFLP for Rapid Genotyping of Polymorphic HFE

Gene. Scientific Journal of Isfahan University of Medical Sciences and Health

Services February 2003 , Vol 7 No 4

39. Mohammad K, Zamani G, Zali MR, Adibi P. Spouse-Spouse Transmission of

Hepatitis B in Iran. Scientific Journal of Isfahan University of Medical

Sciences and Health Services February 2003 , Vol 7 No 4

42

40. Zali MR, Mohammad K, Noorbala AA, Noori Nayer B, Shahraz S, Mohraz M,

Sherafat Kazemzadeh R. Rate of HBsAg Positivity in Iranians Following

Hepatitis B Mass Vaccination. Scientific Journal of Isfahan University of

Medical Sciences and Health Services February 2003 , Vol 7 No 4

41. Zali MR, MoezArdalan Koorosh, Rezaei-Hemami Mohsen, Soltan-Dallal

Mohammad-Mehdi, Rezaiian Mostafa et al. Incidence, Seasonal Trend, and

Antimicrobial Resistance of Shigella in Karaj, Tehran Province, Iran. Iranian Journal of Infectious Diseases and Tropical Medicine January 2003 ,

Vol 7 No 19

42. Zali MR, Shahraz S, Borzabadi S. Bioethics in Iran :Legislation as the Main

Problem. Archives of Iranian Medicine July 2002 , Vol 5 No 3

43. Zali MR, Norouzinia M, Jafar-Nejad P, Vejdani R, Amin G, Nezami A. The

Effects of Herbal Medicines on the Gastrointestinal and Liver Diseases. Hakim February 2002 , Vol 4 No 4

44. Ehsani Ardakani MJ, Jafari mehr A, Hedayati M, Zali MR. Serologic

Frequency of Hepatitis a in Children Who Referred to Tehran Pediatric

Hospitals in 2002. Journal of Zanjan University of Medical Sciences & Health

Services February 2002 , Vol 10 No 41

45. Zali MR, Aghazadeh R, Nowroozi A, Amir-Rasouly H. Anti-HCV Antibody

among Iranian IV Drug Users: is it a Serious Problem? Archives of Iranian

Medicine July 2001, Vol 4 No 3

46. Zali MR, Noroozi A, Amir rasoli H, Darvishi M. The Prevalence of Hepatitic

C Virus and its Routes of Transmission in the Addict Inmmates of Ghasr

Prison, Tehran. Journal of The Faculty of Medicine of Shaheed Beheshti

university of Medical Sciences June 1998 , Vol 22 No 2

47. Zali MR, Yumi M, Ra'ufi M, Noruzi A. GB-C Virus Infection in Patients with

Viral Hepatitis C in Iran: Report on a Preliminary Study. Pajouhandeh

February 1997 , Vol 2 No 4

48. Zali MR. Sclerotherapy of Esophageal Varices. Journal of The Faculty of

Medicine of Shaheed Beheshti university of Medical Sciences December

1985 , Vol 9 No 2

49. Nobakht Haghighi A, Zali MR, Noroozi A. Hepatitis C Antibody and Related

Risk Factors in Hemodialysis. Pajouhandeh August 1980 , Vol 2 No 2

50. Adibi P, Mohammad K, Zali MR. Effect of hepatitis B vaccination on

vaccinated and non-vaccinated children in Iran

Papers Presentation

International

1. Narjes Mehrvar, MSC,∗ Abbas Akhavan Sepahi, PhD, Mahnaz Taremi, MD, MPH,

Masoumeh Azimi Rad, BS, Mohammad Reza Zali, MD, FACG. Characterization

43

Genetic Diversity of 16S-23SrRNA Gene in Salmonella Isolates from Food and

Animal Samples by PCR-Ribotyping. 71th Annual Scientific Meeting of the

American College of Gastroenterology, Las Vegas, October 20-25, 2006.

2. Mohsen Ahmadi Amoli, MD,∗ Maryam Kheradpezhouh, MD, Mahnaz Taremi, MD,

MPH, Latif Gachkar, MD, MPH, MohammadReza Zali, MD, FACG. Prevalence of

TT Virus Infection in Voluntary Blood Donors and Patients on Maintenance

Hemodialysis in Tabriz, Iran. 71th Annual Scientific Meeting of the American

College of Gastroenterology, Las Vegas, October 20-25, 2006

3. Ziba Khorram, MD, Leila Pasharavesh, MD, Arash Etemadi, MD, Roshanak

Roshanfekr, MD, Arash Ghanbarian, MD, Amir Hooshang Mohammad Alizadeh,

MD, Navid Saadat, MD, Farhnaz Fallahian, MD, Mehdi Hedayati, PhD, Seyed

Mohsen Mousavi, PhD, Elaheh Einy, MSc, Farzaneh Kadem Sameni, MD, Reza

Mashayekhi, MD, Maryam Firoozi, BSc, Bahman Talebipoor, MD, Behnaz

Mohabattian, MD, Farzad Hadaaegh, MD, Fereidoun Azizi, MD, Mohammad Reza

Zali, FACG.∗ The Epidemiological Survey of Prevalence of Nonalcoholic Fatty

Liver Disease in Iranian Metabolic Syndrome Adults. 71th Annual Scientific

Meeting of the American College of Gastroenterology, Las Vegas, October 20-25,

2006

4. Leila Alidoust Masouleh, MS, Leila Najafi, MS, Zahra Hajebrahimi, PhD Mohammad

Hossein Somi, MD, Maryam Firoozi, BS, Mohammad Reza Zali, MD.Mannose-

Binding Lectin Gene Polymorphisms in Patients with Chronic Hepatitis B and

Spontaneously Recovered among Iranian Population. 71th Annual Scientific

Meeting of the American College of Gastroenterology, Las Vegas, October 20-25,

2006

5. Leila Najafi, MSc, Zahra Hajebrahimi, PhD, Leila Alidoust, MSc, Mohammad

Hossein Somi, MD, Maryam Firoozi, BSc, Mohammad Reza Zali, FACG. The

Frequency of IL-2, IL-6 and Interferon γ - Genes Polymorphisms in Hepatitis B

Patients in Iran. 71th Annual Scientific Meeting of the American College of

Gastroenterology, Las Vegas, October 20-25, 2006

6. Manouchehr Khoshbaten, Naghmeh Jafarinia, Khalil Ansarin, Reza Fatemi. Amir

Houshang Mohammad Alizadeh, Afsaneh Sharifian, Ziba Khoram, Bahman Talebi

pour, Mohammad Reza Zali,The Role of Endothelin-1 in Cirrhotic Pulmonary

Complication. 71th Annual Scientific Meeting of the American College of

Gastroenterology, Las Vegas, October 20-25, 2006

7. Mohammad Minakari, MD,∗ Mohammadreza Zali, MD, Farzaneh Khademsameni,

MD, Hamid Mohagheghshalmani, MD. Viral and Host Factors Associated with

Steatosis in Iranian Patients with Chronic Hepatitis C. 71th Annual Scientific

Meeting of the American College of Gastroenterology, Las Vegas, October 20-25,

2006

8. Nosratollah Naderi, MD,∗ Alma Farnood, MD, Manijeh Habibi, M.S., Faramarz

Derakhshan, MD, Zahra Motahari, PharmD., Mohammad Reza Agah, MD, Elham

Vali Khojeini, MD, Hedieh Balaii, B.S., Mahta Ghaffarzadeh Rad, B.S., Rahim

Aghazadeh, MD, Homayoun Zojaji, MD, Nasser Ebrahimi Daryani, MD, Babak

Noorinayer, MD, Mohammad Reza Zali, MD, F.A.C.G.Association of Vitamin D

Receptor Gene Polymorphisms with Inflammatory Bowel Disease. 71th Annual

Scientific Meeting of the American College of Gastroenterology, Las Vegas, October

20-25, 2006

44

9. Delnaz Roshandel, MD, Mohammadreza Rezailashkajani, MD, Sepideh Shafaee, MD,

Mohammad Reza Zali, MD, F.A.C.G. A Cost Analysis of Functional Bowel

Disorders in Iran. 71th Annual Scientific Meeting of the American College of

Gastroenterology, Las Vegas, October 20-25, 2006

10. Ali Sadeghi Khasraghi, MD, Rahim Aghazadeh, MD, Amirhoushng

Mohammadalizadeh, MD, Hamid Mohaghegh Shalmani, MD, Noushin Ayoubi, B.S.,

Mohammad Reza Zali, MD, F.A.C.G. Effect of Omeprazole on the Size and

Number of Postbanding Ulcers after Esophageal Variceal Band Ligation: A

Randomised Controlled Trial. 71th Annual Scientific Meeting of the American

College of Gastroenterology, Las Vegas, October 20-25, 2006

11. Mahnaz Taremi, MD, M.P.H.,∗ Mohsen Ahmadi Amoli, MD, Firouzeh Farahtaj,

D.M.T., Haleh Edalatkhah, B.Sc., MohammadReza Zali, MD, F.A.C.G. Genomic

Diversity of Rotavirus Strains Infecting Pediatric Patients in Tehran, Iran. 71th

Annual Scientific Meeting of the American College of Gastroenterology, Las Vegas,

October 20-25, 2006

12. Naghmeh Jafarinia, MD, Sven Lofdahl, PhD, Babak Noorinayer, MD, Nahid

Arjmand, MD, Nazanin HosseinKhan, Microbiologist, Mohammad Reza Zali, MD,

FACG. Clinical Presentation of Diarrhea in Iranian Infants and Young Children

during One Year. 71th Annual Scientific Meeting of the American College of

Gastroenterology, Las Vegas, October 20-25, 2006

13. Saniee M, Golmakani MM, Melati Rad A, Zahedi LD, Shahraz S, Zali MR,

Biotechnology & Intellectual Property Rights: The Aspects in the World and

Iran at a Glance, Proceedings, International Congress of Bioethics, Tehran-Iran,

2005

14. Melati Rad A, Shahraz S, Saniee M, Zahedi LD, Sherafat Kazem-zadeh R, Zali MR,

Attitudes of Iranian Professionals towards Human Cloning, Proceedings,

International Congress of Bioethics, Tehran-Iran, 2005

15. Zahedi LD, Zali MR, Ethical Issues on Publishing of Biomedical Research, Proceedings, International Congress of Bioethics, Tehran-Iran, 2005

16. Ladan Naz Zahedi, Ala Melati Rad, Mansoureh Saniee, Roya Sherafat Kazem-zadeh,

Elnaz Jafarimehr, Saeed Shahraz, Mohammad Reza Zali, Ethical Considerations

on Genetic Tests, Proceedings, International Congress of Bioethics, Tehran-Iran,

2005

17. Ladan Naz Zahedi, Ala Melati Rad, Mansoureh Saniee, Roya Sherafat Kazem-zadeh,

Elnaz Jafarimehr, Saeed Shahraz, Mohammad Reza Zali, Relinquish the Life

Sustaining Supporting Measures: Right or Wrong, Proceedings, International

Congress of Bioethics, Tehran-Iran, 2005

18. Saniee M, Zali MR, How gastroenterology face ethical issues in Iran,

WCOG, Montreal 2005

19. Motahari Z, Zali MR, Lack of association between Vitamin D Receptor

Gene Polimorphisms and Autoimmune Hepatitis in Iranian patients.

WCOG, Montreal 2005

45

20. Farnood A, Naderi N, Noorinayer B, Mirhasani Moghadam SJ, Firoozi F,

Aghazadeh R , Ebrahimi Daryani N, Zali MR, The Frequency of c3435T

Polymorphism of MDR1 Gene in Iranian Patients WithUlcerative Colitis,

13th

United European Gastroenterology Week (UEGW), Copenhagen 2005

21. Hajebrahimi Z, Najafi L, Alidoust L, Somi MH, Agah MR, Zafarghandi M, Zali

MR, Tumor necrosis factor-alpha (TNF-alpha) gene promoter

polymorphisms in patients with chronic HBV and spontaneously recovered

among Iranian Population, 13th

United European Gastroenterology Week

(UEGW), Copenhagen 2005

22. Farnood A, Naderi N, Noorinayer B, Mirhasani Moghadam SJ, Firoozi F,

Aghazadeh R , Ebrahimi Daryani N, Zali MR, The Frequency of 3 common

mutations of CARD 15/NOD2 gene in Iranian IBD Patients, 13th

United

European Gastroenterology Week (UEGW), Copenhagen 2005

23. Jaafari F ,Salmanzadeh S, Habibi E, Zafarghandi M, Baghbani M, Dolatabadi,

Zali MR, Moleculer investigation of E.coli diarrhea in Iranian children

traveling to Tehran, International Medicine and health in the Tropics congress,

Paris 2005

24. Mohammadzadeh Ghobadloo SH, Yaghmaei B, Haghighi Rad F, bakayev V,

Noorinayer B, Zali MR, Polymorphoism of Glutathione s-transferase M1,T1

and P1in patients with HBV Related liver cirrhosis, chronic hepatitis and

normal carriers, European Association for study of liver (EASL) 2005

25. Esteghamat F, Rezvani M, Agah MR, Sendi H, Ghaziani T, Zali MR, HLA

DRBl *04 alleles in autoimmune hepatitis patients frequency and

relationship with response to treatment, European conference of human

genetic, Prague, 2005

26. Najafi L, Hajebrahimi Z, Somi MH, Agah MR, Zafarghandi M, Zali MR,

Frequency of interleukin –2 gene promoter polymorphism at positron –

330 among Iranian patients with chronic hepatitis B infection in Iran, European conference of human genetic, Prague, 2005

27. Motahari Z, Zafarghandi M, Esteghamat F, Agah MR, Zali MR, Genetic

association of vitamin D receptor polymorphisms With autoimmune

hepatitis in Iranian patients, European conference of human genetic, Prague,

2005

28. Abedin N, Noorinayer B, Rahnamaye-chitsaz N, Shahmoradgoli M,

Karimianpour N, Taghizadeh F, Asadzadeh H, Zali MR, Preliminary results

of hMLH1 and hMLH2 mutation analysis among Iranian patients with

HNPCC, European conference of human genetic, Prague, 2005

29. Khatami F, Akhoundi S, Jedi-Tehrani M, Zali MR, Noorinayer B, Mulecular

study on frequency of single nucleotide polymorphism of DNMT1 among

Iranian patients with gastric cancer, European conference of human genetic,

Prague, 2005

46

30. Melati-Rad A, Akhoundi S, Vossoughi M, Jedi-Tehrani M, Zali MR,

Noorinayer B, Mulecular study on frequency of single nucleotide

polymorphism of TP53 among Iranian patients with gastric cancer, European conference of human genetic, Prague, 2005

31. Shahmoradgoli M, Mueller O, Kutzner N, Rostami P, Noorinayer B, Zali MR,

A preliminary moleculer analysis of APC gene in the Iranian FAP patients, European conference of human genetic, Prague, 2005

32. Alidoust Masouleh L, Agah MR, Zafarghandi M, Sendi H, Zali MR,

Association of Glutathion-S-transferase M1,T1 and P1 Gene

Polymorphisms with Autoimmune hepatitis (AIH), European conference of

human genetic, Prague, 2005

33. Farnood A, Naderi N, Noorinayer B, Mirhasani Moghadam SJ, Firoozi F,

Aghazadeh R , Ebrahimi Daryani N, Zali MR, The frequency of C3435 MDRI

gene polymorphism in Iranian patients with Ulcerative colitis, 70th Annual

Scientific meeting of ACG, USA,2005

34. Naderi N, Farnood A, Firoozi F, Rezvani MR, Javery A, Bahari A, Aghazadeh

R , Zali MR, The frequency of three common mutations of CARD15/NOD2

gene in Iranian Patients with Inflammatory bowel disease, 70th Annual

Scientific meeting of ACG, USA,2005

35. Taremi M, Farahtaj F, Gachkar L, Mazaheri Tehrani E, Edalatkhah H,

Zolfagharian K, Zali MR, Moleculer epidemiology and clinical features of

rotavirus infection in Iranian Children, 70th Annual Scientific meeting of

ACG, USA,2005

36. Agah MR, Zafarghandi M, Motahari Z, Jazaeri H, Hajibeigi B, Attarchy Z,

Rajabi T, Zali MR, Ferequency and biochemical expression of

hemochromatosis (HFE) gene Mutations in 1029 blood donors in Iran, 70th

Annual Scientific meeting of ACG, USA,2005

37. Alidoust L, Agah MR, Najafi L, Hajebrahimi Z, Zafarghandi M, Somi MH, Zali

MR, No association between mannose-binding lectin gene polymorphisms

in patients with chronic hepatitis B and spontaneously recovered among

Iranian Population, 70th Annual Scientific meeting of ACG, USA,2005

38. Hajebrahimi Z, Najafi L, Alidoust L, Agah MR, Zafarghandi M, Somi MH, Zali

MR, Tumor necrosis factor-alpha (TNF-alpha) gene promoter

polymorphisms in patients with chronic HBV and spontaneously

recovered among Iranian Population, 70th Annual Scientific meeting of

ACG, USA,2005

39. Melati-Rad A, Vossoughi M, Akhoundi S, Jeddi Tehrani M, Zali MR,

Noorinayer B, Moleculer study on frequency of single nucleotide

polymorphism of TP53 gene among Iranian patients with gastric cancer,

70th Annual Scientific meeting of ACG, USA,2005

40. Firouzi F, Zali MR, Bahari A, Ebrahimi Daryani N, Aghazadeh R, Mehdi

Emam M ,Mohaghegh Shalmani H. Corticoteroid-Induced osteoporosis and

47

osteopenia in inflammatory bowel disease, 70th Annual Scientific meeting

of ACG, USA,2005

41. Steghamat F, Ghaziani T, Sendi H, Rezvani MR, Agah MR, Zali MR, 44244

HLA DRB1*04 in Autoimmune Hepatitis Patients-Frequency and

Relationship with Response to Treatment, Digest Disease Week, Chicago,

2005

42. Steghamat F, Zali MR. HLA DRB1*04 in autoimmune hepatitis patients-

frequency and relationship with response to treatment, Digest Disease

Week, Chicago, 2005

43. Alidoust L, Zafarghandi M, Agah MR, Sendi H, Zali MR. Association of

glutathion-S-transferase M1, T1 and P1 gene polymorphisms Iranian

population. Digest Disease Week, Chicago, 2005

44. Motahari Z, Zafarghandi M, Steghamat F, Agah MR, Zali MR. Genetic

association of vitamin D receptor polymorphisms with autoimmune

hepatitis in Iranian patients . Digest Disease Week, Chicago, 2005

45. Jazayeri M, Bakayev V, Zali MR, Mohaghegh H, Esmaeili A, Haghighirad F,

Zakeri H, Kalantar E, Sharaz S, Adibi P. Comparison of relative frequency of

hfe gene mutations in minor beta-thalassemia and healthy population in

Tehran, 14th Biennial Conference of APASL, India, 2004

46. Firoozi F, Zali MR et al, MDR1 C3435t Polymorphism is not Associated

with Ulcerative Colitis in Iranians, American College of Gastroenterology,

69h Annual Scientific Meeting, USA, 2004

47. Saniee M, Zali MR et al, Knowledge, Attitudes and Practices of GI and

Endoscopy Nurses in Iran, American College of Gastroenterology, 69h

Annual Scientific Meeting, USA, 2004

48. Roushandel D, Zali MR et al, Internet use by a referral Gastroenterology

clinic population and medical information preferences, American College

of Gastroenterology, 69h Annual Scientific Meeting, USA, 2004

49. Rezaee R, Zali MR et al, Clinical characteristics of autoimmune hepatitis: a

survey of 46 patients, American College of Gastroenterology, 69h Annual

Scientific Meeting, USA, 2004

50. Firoozi F, Zali MR et al, Appendectomy, Tonsillectomy, Oral

Contraceptive, Nsaid and Risk of Inflammatory Bowel Disease: A Case-

Control Study in Iran, American College of Gastroenterology, 69h Annual

Scientific Meeting, USA, 2004

51. Taremi M, Zali MR et al, Epidemiological aspect of Rotavirus Infections in

Ahvaz, Iran, American College of Gastroenterology, 69h Annual Scientific

Meeting, USA, 2004

48

52. Hajaliaskar, Zali MR et al, Association of the CTLA-4 G allele

polymorphism at position 49 in exon 1 with the susceptibility to

Autoimmune Hepatitis (AIH) in Iranian population, American College of

Gastroenterology, 69h Annual Scientific Meeting, USA, 2004

53. Esteghamat S, Zali MR et al, C77G mutation in the CD45 gene in Iranian

patients with autoimmune hepatitis and controls, 12th

UEGW, Prague, 2004

54. Roushandel D, Zali MR et al, Laboratory characteristics of autoimmune

hepatitis in 46 Iranian patients, 12th

UEGW, Prague, 2004

55. Rezaee R, Zali MR et al, An economic analysis of premarriage prevention of

hepatitis B transmission in Iran, 12th

UEGW, Prague, 2004

56. MoezArdalan K, Salmanzadeh –Ahrabi S, habibi E, Jaafari F, Edalatkhah H,

MoezArdalan S, Zolfagharian K, Rezaei Hemami M, Zali MR, The role of

diarrheagenic Escherichia coli in diarrhea of children in Karaj, Iran, 11th

United European Gastroenterology Week (UEGW) , Madrid,2003

57. Mirhassani Moghaddam SM, Zali MR, Taghizadeh F, Noroozi N, Narimani M,

peyman S, Derakhshan F, MEFV gene Mutations in Iranian patients with

familial Mediterranean faver, 11th

United European Gastroenterology Week

(UEGW) , Madrid,2003

58. Mirhassani Moghaddam SM, Zali MR, Samie S, Shahid N, NobakhtHaghighi

E, Keramati A, Asadzadeh H, Daneshmand M.Immunohistochemical Analysis

of P53, cyclin D1, Rb, C-fos and N-Ras genes expression in hepatocellular

carcinoma in Iran, 11th

United European Gastroenterology Week (UEGW) ,

Madrid,2003

59. Asadzadeh Aghdaee H, Zali MR, New mutations in APC and B-catenin

Gene in WNT signaling pathway in Iranian Gastric Adenocarcinom, 11th

United European Gastroenterology Week (UEGW) , Madrid,2003

60. Aghazadeh R, Zali MR, Inflammatory bowel disease in Iran: A Review of

448 cases, 11th

United European Gastroenterology Week (UEGW) ,

Madrid,2003

61. Abbaszadegan MR, Zali MR, The expression of E-cadherin in Gastric

carcinoma: A clinical pathological study, 11th

United European

Gastroenterology Week (UEGW), Madrid 2003

62. Peyman S, Zali MR, Molecular detection of germline mutations of the

hMLH1 & hMSH2 genes among Iranian HNPCC patients,11th

United

European Gastroenterology Week (UEGW) , Madrid,2003

63. Moez Ardalan K, Zali MR, Enteroaggregative Escherichia coli associated

with acute diarrhea in children, a case- control study, 13th

European

Congress of Clinical Microbiology and Infectious Diseases (ECCMID),

Glasgow 2003

49

64. Hekmatdoost A, Zali MR, A review of hepatitis B transmission in an

organized registry center, Tehran, Iran. 13th

European Congress of Clinical

Microbiology and Infectious Diseases (ECCMID), Glasgow 2003

65. Ehsani Ardakani MJ, Zali MR, Hepatitis C in rheumatoid arthritis patients,

13th

European Congress of Clinical Microbiology and Infectious Diseases

(ECCMID), Glasgow 2003

66. Ardalan K, Zali MR, Etiological study of diarrheal patients and the pattern

of antimicrobial resistance in Karaj, Tehran, Iran, 13th

European Congress

of Clinical Microbiology and Infectious Diseases (ECCMID), Glasgow 2003

67. Zali MR, Assessment and comparison of eating behavior, SFA intake and

GE problem in dormitory and non-dormitory living university

student,Tehran,Iran, 9th

European Nutrition Conference, Rome 2003

68. Zali MR, Etiological study of diarrheal patients and the pattern of antimicrobial

resistance in Karaj, Tehran, Iran, International Medical Science Students

Conference, 2003

69. Zali MR, Sadzadeh Aghdaee H, Gasparian A, Noorinayer B, Molecular

Detection of Germline Mutation of the hMLH1 & hMSH2 genes Among

Iranian HNPCC patients, 68th

American College of Gastroenterology, USA

2003

70. Zali MR, Mirhassani Moghaddam SJ, Samie S, Immunohistochemical

analysis of P53, RB, C-FOS and N-RAS genes expression in Hepatocellular

Carcinoma in Iran, 68th

American College of Gastroenterology, USA 2003

71. Zali MR, Vossoughi M, Mirhassani Moghaddam SJ, Noorinayer B, The

relationship between TT Virus and cryptogenic liver disease among

Iranian patients, 68th

American College of Gastroenterology, USA 2003

72. Zali MR, Sima HR, Hekmatdoost A, Seroprevalence of Celiac diseases in

Autoimmune Hepatitis and chronic hepatitis B, 68th

American College of

Gastroenterology, USA 2003

73. Jafari Mehr A, Ehsani Ardakani MJ, Zali MR, Age – Specific seroprevalence

of Hepatitis A infection among Children visited in pediatric hospitals of

Tehran, Iran, 68th

American College of Gastroenterology, USA 2003

74. Zali MR, Masjedizadeh A, Atrophic gastritis and helicobacter pylori

infection in patients with reflux esophagitis: A case – control study, 68th

American College of Gastroenterology, USA 2003

75. Zali MR, MoezArdalan K, The role of Diarrheagenic Escherichia coli in

acute diarrhea of children in Karaj, Iran, 68th

American College of

Gastroenterology, USA 2003

51

76. Zali MR, MirhassaniMoghaddam SJ, MEFV Gene mutations in Iranian

Patients with familial Mediterranean fever (FMF), 68th

American College of

Gastroenterology, USA 2003

77. Zali MR, Aghazadeh R, Seroprevalence of Celiac diseases in Inflammatory

Bowel disease, 68th

American College of Gastroenterology, USA 2003

78. Effat Habibi, Zali MR, Serotyping of GroupA Rotaviruses in children less

than 7 years old in Tehran, 68th

American College of Gastroenterology, USA

2003

79. Zali MR, P53, Rb and cyclin D1 genes expression in Esophageal Squmous

cell Carcinoma in Iran, 104th

Annual Meeting of the American

Gastroenterological Association, 2003

80. Zali MR, New mutation in APC and B-catenin gene in WNT signaling

pathway in Iranian Gastric Carcinoma, 104th

Annual Meeting of the

American Gastroenterological Association, 2003

81. Sendi H, Ghaziani T, Zali MR, Distribution of HFE mutation in HBs Ag

postitive patient, 104th

Annual Meeting of the American Gastroenterological

Association, 2003

82. Sahrokh Mohammadzadeh, Zali MR, GSTP1, GSTM1 Gene Polymorphysm

in patients withCryptogenic Liver Cirrhosis, 104th

Annual Meeting of the

American Gastroenterological Association, 2003

83. Zali MR, Polymorphism of the CYP2C19 gene in a systematic sample of the

Nahavand population, International Genetics Congress, Dubai, 2003

84. Mohammadzadeh Ghobadloo SH, Yaghmaei B, Bakayev V, Zali MR, GSTP1,

GSTM1, and GSTT1 in patients with cryptogenic liver Cirrhosis, 38th

EASL, Annual meeting of the European Association for the study of the Liver,

Turkey, 2003

85. Adibi P, Zamani G, Mohammad K, Zali MR, Parent – children transmission

of hepatits B in Iran, 38th

EASL, Annual meeting of the European Association

for the study of the Liver, Turkey, 2003

86. Zali MR, Noorinayer B, Shahraz S, Rate of HBS Ag positivity in Iran

following hepatitis B mass vaccination, 38th

EASL, Annual meeting of the

European Association for the study of the Liver, Turkey, 2003

87. Bakayev V, Zali MR, Comparison of relative frequency of HFE gene

mutation in minor beta- thalassemia and healthy population in Tehran, 38th

EASL, Annual meeting of the European Association for the study of the Liver,

Turkey, 2003

Domestic

51

1. Esteghamat F, Noorinayer B, Sanati MH, Hekmatdoost A, Mohaghegh

shalmani H, Agah MR, Zali MR. C77G Mutation In CD45 Gene And

Autoimmune Hepatitis: A Controversial Deba, ICGH4-FBB2, Tehran, 2004

2. Roshandel D, Rezailashkajani MR, Ansari S, Zali MR. Internet use by a

referral gastroenterology clinic population and their medical information

preferences, ICGH4-FBB2, Tehran, 2004

3. Eyvazzadeh L, Vahidi R, Sima HR, Mashayekh A, Mohammad Alizadeh AH,

Ehsani Ardakani MJ, Alavian SM, Ayasofi K, Zali MR. Food intake and

dietary habit in iranian patients with non-alcoholic steatohepatitis,

ICGH4-FBB2, Tehran, 2004

4. Habibi E, Salmanzadeh S, Rezaei M, Moez ardalan K, Jaafari F, Edalatkhah H,

Moez ardalan S, Zolfagharian K, Azimi rad M, Zali MR. Bacterial

epidemiology of acute diarrhea in Varamin-Tehran-Iran( Nov.2002-

Nov.2003), ICGH4-FBB2, Tehran, 2004

5. Shavakhi A, Zafarghandi M, Agah MR, Ghambili J, Firouzi L, Zali MR. Helicobacter pylori infection in Iranian patients with chronic

hepatitis: any role in their prognosis? ICGH4-FBB2, Tehran, 2004

6. Shavakhi A, Esteghamat F, Sharifian A, Aghazadeh R, Mohammadalizadeh

AH, Hekmatdoost A, Khodadoostan M, Firoozi M, Zali MR. HEV infection

in patients with chronic liver disease, ICGH4-FBB2, Tehran, 2004

7. Rezailashkajani MR, Roshandel D, Hekmatdoost A, Mohaghegh shalmani H,

Ghaziani T, Sendi H, Alavian SM, Sherafatkazemzadeh R, Sima HR, Zali MR.

Clinical characteristics of autoimmune hepatitis: a study of 46 patients,

ICGH4-FBB2, Tehran, 2004

8. Salmanzadeh-ahrabi S, Habibi E, Jaafari F, Zali MR. Molecular

epidemiology of escherichia coli diarrhea in children in Tehran,

ICGH4-FBB2, Tehran, 2004

9. Alidoust L, Agah MR, Sendi H, Zali MR. Association Of Glutathion-S-

transferase M1,T1 and P1 Gene Polymorphisms With Autoimmune

Hepatitis (AIH) In Iranian Population, ICGH4-FBB2, Tehran, 2004

10. Mohammad Alizadeh AH, Salmanzadeh S, Ranjbar M, Behrouz N, Azimian

MH, Ejmalian S, Doorooozi T, Rabee yeganeh M, Chavoshi A, Zali MR. Frequency of e.coli, shigela and salmonella in acute diarrhea in

hamedan (summer 2003), ICGH4-FBB2, Tehran, 2004

11. Honarkar Z, Alavian SM, Samiee S, Saeedfar K, Zali MR. HBc antibody and

Occult Hepatitis B, ICGH4-FBB2, Tehran, 2004

12. Honarkar Z, Alavian SM, Samiee S, Saeedfar K, Zali MR. Occult Hepatitis

B as a Cause of Cryptogenic Cirrhosis, ICGH4-FBB2, Tehran, 2004

13. Hajialiasgar S, Agah MR, Rezvani MR, Hekmatdoost A, Esteghamat F, Zali

MR. Association of the CTLA-4 G allele polymorphism at position 49

52

in exon 1 with the susceptibility to Autoimmune Hepatitis (AIH) in

Iranian population, ICGH4-FBB2, Tehran, 2004

14. Hashemi habib abadi M, Bahari A, Hedayati M, Arabi M, Samie S, Rad S, Zali

MR. Frequency of Celiac Disease in Patients with Flatulence /

Bloating Complaint, ICGH4-FBB2, Tehran, 2004

15. Aarabi M, Bahari A, Hedayati M, Jarollahi A, Habibi M, Aghazadeh R, Zali

MR. Diagnostic Value of perinuclear Antineutrophil Cytoplasmic

Antibody and Anti-Saccharomyces Cerevisiae Antibody in Iranian

Patients with Inflammatory Bowel Disease, ICGH4-FBB2, Tehran, 2004

16. Mahmazi S, Noorinayer B, Rostami P, Ansari S, Mohamadalizadeh AH, Jeddi-

tehrani M, Zali MR. study polymorphisms of CYP2C19 gene among a

systematic sample of nahavand population, ICGH4-FBB2, Tehran, 2004

17. Jodeiri B, Somi MH, Moosapour H, Taheri E, Zali MR. A review of

esophageal manometry testing in Taleghani hospital, ICGH4-FBB2, Tehran,

2004

18. Jodeiri B, Somi MH, Moosapour H, Aghdai M, Zali MR. Is esophageal body

motility disorder ,a marker for gastroesophageal reflux disease? ICGH4-

FBB2, Tehran, 2004

19. Jodeiri B, Somi MH, Moosapour H, Taheri E, Zali MR. Esophageal

manometry in dysphagia: a comparison of findings in younger and older

patients, ICGH4-FBB2, Tehran, 2004

20. Jodeiri B, Taheri E, Moosapour H, Somi MH, Zali MR. Review of achalasia

in Iran, ICGH4-FBB2, Tehran, 2004

21. Somi MH, Najafi L, Noori nayer B, Mohammad alizadeh AH, Agah MR, Ansari

S, Shavakhi A, Ehsani Ardakani MJ, Aghazadeh R, Zand S, Amini S, Zali

MR. Tumor Necrosis factor- alpha (TNF- alpha) gene promoter

polymorphism at position -308 frequency among patients with

chronic HBV and spontaneously recovered subjects, ICGH4-FBB2,

Tehran, 2004

22. Masoodi M, Zali MR, Mohammad alizadeh AH, Aghazadeh R, Ehsani

Ardakani MJ, Noori nayer B, Somi MH, Yazdani S, Shavakhi A, Antikchi MH,

Arjmand shabestari A, Honarkar Z. Serum insulin-like growth factor-I

and tumor size in patients with metastatic liver cancer, ICGH4-FBB2,

Tehran, 2004

23. Masoodi M, Aghazadeh R, Moussavi H, Ehsani Ardakani MJ, Mohammad

alizadeh AH, Somi MH, Shavakhi A, Yazdani S, Antikchi MH, Zali MR.

Ethical Aspect in Gastrointestinal Endoscopy in Iran, ICGH4-FBB2,

Tehran, 2004

24. Masoodi M, Zali MR, Aghazadeh R, Mohammad alizadeh AH, Ehsani

Ardakani MJ, Arjmand Shabestari A, Somi MH, Antikchi MH, Yazdani S,

Shavakhi A. Cholecystocolic fistula due to adenocarcinoma of the

colon, ICGH4-FBB2, Tehran, 2004

53

25. Bahari A, Firouzi F, Zali MR, Aghazadeh R, Maleki B, Ardalan A. Appendectomy, tonsillectomy, oral contraceptive, NSAIDs and risk

of inflammatory bowel disease: a case-control study in Iran, ICGH4-

FBB2, Tehran, 2004

26. Masoodi M, Zali MR, Ehsani Ardakani MJ, Mohammad alizadeh AH, Aiassofi

K, Aghazadeh R, Shavakhi A, Somi MH, Antikchi MH, Yazdani S. Abdominal

pain due to lead-contaminated opium as a new source of inorganic-

lead poisoning in Iran, ICGH4-FBB2, Tehran, 2004

27. Ehsani Ardakani MJ, Yazdani S, Emadian L, Peyravi H, Ariapoor A, Noori

nayer B, Masoodi M, Zali MR. Endoscopic ultrasonography in

preoperative staging of gastrointestinal cancer in comparisons with

surgical staging, ICGH4-FBB2, Tehran, 2004

28. Sima HR, Ghadiri A, Khajedalouei M, Ardalan K, Hoseinimoghadam MM,

Hassani R, Zali MR. Assessment of general practitioners performance

in diagnosis, treatment, education and follow-up of patients with

acute diarrhea in Shahrood, ICGH4-FBB2, Tehran, 2004

29. Hekmatdoost A, Sima HR, Alavian SM, Ghazian T, Mashayekh A, Arabi M,

Mohseni M, Zali MR. Celiac disease: An iceberg in patients with

hepatitis B? ICGH4-FBB2, Tehran, 2004

30. Sima HR, Mashayekh A, Hedayati M, Samiee S, Arjomand shabestari A,

Alavian SM, Mohammad alizadeh AH, Ehsani Ardakani MJ, Ayasoofi K, Zali

MR. Insulin resistance in Iranian patients with Nonalcoholic

Steatohepatitis, ICGH4-FBB2, Tehran, 2004

31. Sima HR, Mashayekh A, Eyvazzadeh L, Arjomand shabestari A, Hedayati M,

Alavian SM, Mohammad alizadeh AH, Ayasoofi K, Zali MR. The efficacy of

the standardized diet in management of Iranian patients with

Nonalcoholic Steatohepatitis, ICGH4-FBB2, Tehran, 2004

32. Fatemi R, Mohammad alizadeh AH, Khoshbaten M, Talebipor B, Sharifian A,

Khoram Z, Sheikholeslami FH, Shirazi MG, Mohaghegh shalmani H, Zali

MR. Evaluation of clinical charactristic and diagnosis of

hepatopulmonary syndrome in Iranian cirrhotic patient, ICGH4-

FBB2, Tehran, 2004

33. Vossoughi M, Sharifpanah F, Tirgari F, Mohagheghi A, Zali MR, Noorinayer

B. CyclinD1 G870A Single nucleotide polymorphism is not associated

with Gastric Cancer Among Iranian patients. A Pilot Genetic

Association Study, ICGH4-FBB2, Tehran, 2004

34. Khoshbaten M, Taremi M, Ghachkar L, Mahmoud arabi SM, Argani H,

Abediazar S, Zolfagharian K, Zali MR. Hepatitis E virus infection in

hemodialysis patients: A seroepidemiological survey in Iran, ICGH4-

FBB2, Tehran, 2004

35. Ansari S, Mohammad alizadeh AH, Ranjbar M, Jafarimehr A, Adibi P, Mirarab

A, Habibi M, Arabi M, Firouzi M, Jazayeri, H, Zali MR. Seroprevalence of

Hepatitis A IgG in the Population of 6 yr and Bigger in Nahavand

City: A Population Based Study in 2003, ICGH4-FBB2, Tehran, 2004

54

36. Mohammad alizadeh AH, Ansari S, Mohaghegh shalmani H, Honarkar Z,

Ardalan A, Ranjbar M, Baladast M, Arabi M, Arabi M, Firouzi M, Belar N,

Zali MR. Seroprevalence of Hepatitis A IgG in the Population of 6 yr

and Bigger in Soroprevalence of Helicobacter Pylori in Navand, west

of Iran: A Population based study, ICGH4-FBB2, Tehran, 2004

37. Mohammad alizadeh AH, Antikchi MH, Sharifzadeh M, Ehsani Ardakani MJ,

Yazdani S, Masoodi M, Somi MH, Shavakhi A, Zali MR. Outcome of

nutritional support in patients with percutaneos Endoscopic

gastrostomy, ICGH4-FBB2, Tehran, 2004

38. Yazdani S, Masoodi M, Antikchi MH, Somi MH, Shavakhi A, Aghazadeh R,

Ehsani Ardakani MJ, Mohammad alizadeh AH, Zali MR. Prevalence of

irritable bowel syndrome among medical students of Taleghani

hospital, ICGH4-FBB2, Tehran, 2004

39. Adibi P, Mohammad K, Zali MR. Effect of hepatitis B vaccination on vaccinated

and non-vaccinated children in Iran, ICGH3, Tehran, 2003

40. Adibi P, Baladast M, Ehsani Ardekani MJ, Zali MR. Optimal time for reading

routine rapid (biopsy) urease test result, ICGH3, Tehran, 2003

41. Adibi P, Shahraz S, Rahimi H, Kiani Amin F, Ghasssemian R, Hekmatdoost A, Zali MR. Is Hepatitis B screening in pregnant mothers cost-effective? ICGH3, Tehran, 2003

42. Ehsani MJ, Shavakhi A, Khodadoostan M, Miri MM, Mahmoud Arabi SM, Zali

MR, Adibi P. Hepatitis a Vaccination is not Necessary for Iranian Patients with Chronic Liver Disease, ICGH3, Tehran, 2003

43. Moradi Moghaddam F, Hekmatdoost A, Sajednia F, Zali MR. Diagnostic role of

percutaneous liver biopsy after other diagnostic workups in patients with focal liver lesions, ICGH3, Tehran, 2003

44. Adibi P, Alavian SM, Mohamadlizadeh AH, Mohaghegh H, Ranjbar M, Sima HR, Ehsani Ardekani MJ, Zali MR. Discrimination functions to predict liver fibrosis and cirrhosis in hepatitis C, ICGH3, Tehran, 2003

45. Adibi P, Alavian SM, Mohamadlizadeh AH, Mohaghegh H, Ranjbar M, Sima HR, Zali MR. Could a clinician decide about HCV treatment without liver biopsy: estimating clinical decision prediction and statistical agreement, ICGH3, Tehran, 2003

46. Hashemi SJ, Zali MR. The Role of esophageal motility disorders in

Gastroesophageal Reflux diseas(GERD), ICGH3, Tehran, 2003

47. Sima HR, Mashayekh A, Eyvazzadeh L, Hedayati M, Alavian SM, Mohammad Alizadeh AH, Ayasoofi K, Zali MR. The Eficacy of ohe Standardized Diet in Management of Patients with Nonalcoholic Steatohepatitis, , ICGH3, Tehran, 2003

48. Sima HR, Hekmatdoost A, Ghaziani T, Alavian SM, Arabi SM, Mohaghegh Shalmani H, Sendi H, Mohseni M, Mashayekh A, Zali MR. Seroprevalence of Celiac Disease in Autoimmune Hepatitis and Chronic Hepatitis B, ICGH3, Tehran, 2003

55

49. Bahari A, Aarabi M, Hedayati M, Samie S, Aghazadeh R, Zali MR. Seroprevalence of Celiac Disease in Inflammatory Bowel Disease, ICGH3, Tehran, 2003

50. Adibi P, Ghotbi H, Noroozinia M, Ghaziani M, Hatami S, Shahraz S, Zali MR. Cost-Effectiveness of Mass Vaccination of All Teenagers Against Hepatitis B, ICGH3, Tehran, 2003

51. Masjedizadeh R, MoezArdalan K, Zali MR. Atrophic Gastritis and Helicobacter Pylori Infection in Patients with Reflux Esophagitis: A Case-Control Study, ICGH3, Tehran, 2003

52. Sendi H, Ghaziani T, Agah MR, Aghabozorgi S, Mohammad Alizadeh AH, Zali MR. Hepatitis C Virus Genotypes in 45 Iranian Patients, ICGH3, Tehran, 2003

53. Sendi H, Ghaziani T, Noorinayer B, Edrissian MO, Javeri, Mirhassani Moghaddam SJ, Sami, Esteghamat, Zali MR. Human Papilloma Virus-16 and 18 DNA And Epstein-Bar Virus DNA In Esophageal Squamous Cell Carcinoma, ICGH3, Tehran, 2003

54. . Sima HR, Hekmatdoost A, Ghaziani T, Alavian SM, Arabi SM, Mohaghegh Shalmani H, Sendi H, Mohseni M, Mashayekh A, Zali MR Seroprevalence of hepatitis B markers in Nahavand-Iran: A population based study in 2003, ICGH3, Tehran, 2003

55. Zali MR, Aghazadeh R, Bahari A, Ghahghai F, Amin K, Firouzi F. Inflammatory Bowel Disease in Iran; A Report of 450 Cases, ICGH3, Tehran, 2003

56. Honarkar Z, Saeedfar K, Alavian SM, Amini S, Samiee S, Zali MR. Frequency Of Occult Hepatitis B )OHB in Chronic Liver Diseases, ICGH3, Tehran, 2003

57. Honarkar Z, Saeedfar K, Alavian SM, Amini S, Samiee S, Zali MR. Sensitivity of Immunohistochemistry )IHC( in Occult Hepatitis B )OHB( Diagnosis) , ICGH3, Tehran, 2003

58. Mirhassani Moghaddam SJ, Daneshmand MA, Shahid N, Samiee S, Norouzi N, Tavakoli M, Zali MR. P53, Cyclin D1 ,Rb, c-fos And N-Ras Genes Expression Changes In Hepatocellular Carcinoma In Iran, ICGH3, Tehran, 2003

59. Mohammad alizadeh AH, Aghazadeh R, Ehsani ardakani MJ, Antikchi MH, Beladi Moghaddam N, Zali MR, Ebtia M. Outcome of Patients Who Have Undergone Percutaneous Endoscopic Gastrostomy for Nutritional Support, ICGH3, Tehran, 2003

60. Mahmazi S, Noorinayer B, Seyedi S, Jeddi-tehrani M, Zali MR. Polymorphisms of CYP2C19 Gene Among a Systematic Sample of Nahavand Population, ICGH3, Tehran, 2003

61. Adibi P, Rezailashkajani MR, Roshandel D, Behrooz N, Ansari S, Sajednia F, Shahraz S, Zali MR. Assessing Economic Aspects of Preventing Intra-Familial HBV Transmission in Pre-Marriage Stage in Iran, ICGH3, Tehran, 2003

62. Mohammad Alizadeh AH, Ranjbar M, Adibi P, Behrouz N, Zali MR. Virologic Characteristics of Patients Presenting With Chronic Hepatitis B Infection, ICGH3, Tehran, 2003

63. Salmanzade –Ahrabi S, Baghbani Arani F, Jaafari F, Habibi E, Zali MR. Detection of shiga-toxin producing Escherichia coli(STEC) in meat samples marketed in Tehran by polymerase chain reaction(PCR), Microbiology Congress, Semnan, 2005

56